2021	PMC7836272	cep57	depletion	We recently reported that the Cep57–PCNT interaction is crucial for the maintenance of centriole engagement during mitosis and that depletion of Cep57 causes precocious centriole disengagement in mitosis, but not in interphase (mitosis, 42.2 ± 5.1%; interphase, 0%;  n  = 30 and 50, respectively, from three independent experiments;  Fig. 1, A and B ;  Watanabe et al., 2019 ).	 We recently reported that the Cep57–PCNT interaction is crucial for the maintenance of centriole engagement during mitosis and that [EXPE] of [GENE] causes precocious centriole disengagement in mitosis but not in interphase  mitosis 422 ± 51%; interphase 0%;  n  = 30 and 50 respectively from three independent experiments;  Fig 1 A and B ;  Watanabe et al 2019   
2021	PMC7836272	cep57l1	depletion	We found that depletion of Cep57L1 did not affect centriole engagement in either interphase or mitosis ( Fig. 1 E ).	 We found that [EXPE] of [GENE] did not affect centriole engagement in either interphase or mitosis   Fig 1 E   
2021	PMC7836272	cep57	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins [GENE] Cep57L1 and PCNT by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	cep57l1	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins Cep57 [GENE] and PCNT by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	pcnt	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins Cep57 Cep57L1 and [GENE] by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	cep57	sirnas	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the [EXPE] was validated by quantifying mRNAs using quantitative RT-PCR  RT-qPCR  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	rt-pcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative [EXPE]  RT-qPCR  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	rt-qpcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR  [EXPE]  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	sirnas	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the [EXPE] was validated by quantifying mRNAs using quantitative RT-PCR  RT-qPCR  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	rt-pcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative [EXPE]  RT-qPCR  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	rt-qpcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR  [EXPE]  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	sirna	The phenotypes provoked by codepletion of Cep57 and Cep57L1 were also confirmed by using a different siRNA and other human cell lines ( Fig. S1, E and F ).	 The phenotypes provoked by codepletion of [GENE] and Cep57L1 were also confirmed by using a different [EXPE] and other human cell lines   Fig S1 E and F   
2021	PMC7836272	cep57l1	sirna	The phenotypes provoked by codepletion of Cep57 and Cep57L1 were also confirmed by using a different siRNA and other human cell lines ( Fig. S1, E and F ).	 The phenotypes provoked by codepletion of Cep57 and [GENE] were also confirmed by using a different [EXPE] and other human cell lines   Fig S1 E and F   
2021	PMC7836272	cep57	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant [GENE] or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] [GENE] or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or [GENE] construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or [GENE] construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + [GENE] expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + [GENE] expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + [GENE] expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + [GENE] expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	depletion	The efficiency of the CRISPR/Cas9-mediated depletion was validated by measuring the signal intensities of Cep57 and Cep57L1 at the centrosomes ( Fig. S1, I and J ).	 The efficiency of the CRISPR/Cas9-mediated [EXPE] was validated by measuring the signal intensities of [GENE] and Cep57L1 at the centrosomes   Fig S1 I and J   
2021	PMC7836272	cep57l1	depletion	The efficiency of the CRISPR/Cas9-mediated depletion was validated by measuring the signal intensities of Cep57 and Cep57L1 at the centrosomes ( Fig. S1, I and J ).	 The efficiency of the CRISPR/Cas9-mediated [EXPE] was validated by measuring the signal intensities of Cep57 and [GENE] at the centrosomes   Fig S1 I and J   
2021	PMC7836272	cep57	depletion	  (A)  Depletion of Cep57 induced precocious centriole disengagement in mitosis, but not in interphase.	    A   [EXPE] of [GENE] induced precocious centriole disengagement in mitosis but not in interphase 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against [GENE]  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against CP110  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against CP110  green  and [GENE]  red  
2021	PMC7836272	cep57	rescued	 (G)  Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was rescued by exogenous expression of Cep57 or Cep57L1.	   G   Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was [EXPE] by exogenous expression of [GENE] or Cep57L1 
2021	PMC7836272	cep57l1	rescued	 (G)  Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was rescued by exogenous expression of Cep57 or Cep57L1.	   G   Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was [EXPE] by exogenous expression of Cep57 or [GENE] 
2021	PMC7836272	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), CENP-F (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against FLAG  green  CENP-F  red  and [GENE]  cyan  
2021	PMC7836272	cep57	depletion	Double depletion of Cep57 and Cep57L1 causes precocious centriole disengagement in interphase.	 Double [EXPE] of [GENE] and Cep57L1 causes precocious centriole disengagement in interphase 
2021	PMC7836272	cep57l1	depletion	Double depletion of Cep57 and Cep57L1 causes precocious centriole disengagement in interphase.	 Double [EXPE] of Cep57 and [GENE] causes precocious centriole disengagement in interphase 
2021	PMC7836272	cep57l1	alignments	  (A)  Alignments of full-length  H. sapiens  Cep57L1 and Cep57.	    A   [EXPE] of full-length  H sapiens  [GENE] and Cep57 
2021	PMC7836272	cep57	alignments	  (A)  Alignments of full-length  H. sapiens  Cep57L1 and Cep57.	    A   [EXPE] of full-length  H sapiens  Cep57L1 and [GENE] 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against centrin (green), Cep192 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against centrin (green), Cep192 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  Cep192  red  and [GENE]  cyan  
2021	PMC7836272	cep57	rt-qpcr	 (D)  Expression levels of Cep57 and Cep57L1 were quantified by RT-qPCR in control and Cep57/Cep57L1-depleted cells.	   D   Expression levels of [GENE] and Cep57L1 were quantified by [EXPE] in control and Cep57/Cep57L1-depleted cells 
2021	PMC7836272	cep57l1	rt-qpcr	 (D)  Expression levels of Cep57 and Cep57L1 were quantified by RT-qPCR in control and Cep57/Cep57L1-depleted cells.	   D   Expression levels of Cep57 and [GENE] were quantified by [EXPE] in control and Cep57/Cep57L1-depleted cells 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57 and siCep57L1 no. 2 and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57 and siCep57L1 no 2 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep192	immunostained	U2OS cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep192 (red).	 U2OS cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep192	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep57	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of [GENE] and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  ODF2  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	cep57l1	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of Cep57 and [GENE] is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  ODF2  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	odf2	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  [GENE]  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	cep57	suppress	Taken together, these data suggest that Cep57 and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus suppress centriole reduplication within the same cell cycle.	 Taken together these data suggest that [GENE] and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus [EXPE] centriole reduplication within the same cell cycle 
2021	PMC7836272	cep57l1	suppress	Taken together, these data suggest that Cep57 and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus suppress centriole reduplication within the same cell cycle.	 Taken together these data suggest that Cep57 and [GENE] cooperatively regulate the maintenance of centriole engagement during interphase and thus [EXPE] centriole reduplication within the same cell cycle 
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and ODF2 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep295	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep295 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  CP110  red  and PCNA  cyan  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against PCNT  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against PCNT  green  CP110  red  and [GENE]  cyan  
2021	PMC7836272	pcnt	immunostained	HeLa cells were immunostained with antibodies against PCNT (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  and CP110  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were immunostained with antibodies against PCNT (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against PCNT  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostaining	HeLa cells were treated with siControl or siCep57/Cep57L1 and followed by nocodazole treatment (10 µM) for 3 h. After nocodazole treatment, the cells were cold treated for 1 h, followed by 1-min incubation at 37°C and immunostaining with antibodies against EB1 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and followed by nocodazole treatment  10 µM  for 3 h After nocodazole treatment the cells were cold treated for 1 h followed by 1-min incubation at 37°C and [EXPE] with antibodies against EB1  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 for 36 h in the presence of EdU (S phase marker; cyan) for the last 30 min before fixation and immunostained with antibodies against CP110 (red) and CENP-F (green).	 HeLa cells were treated with siControl or siCep57/Cep57L1 for 36 h in the presence of EdU  S phase marker; cyan  for the last 30 min before fixation and [EXPE] with antibodies against [GENE]  red  and CENP-F  green  
2021	PMC7836272	cdk1	inhibitor	Previous studies have reported that the G 2  phase cell cycle arrest induced by treatment with a Cdk1 inhibitor or DNA-damaging reagents caused precocious centriole disengagement ( Prosser et al., 2012 ;  Douthwright and Sluder, 2014 ).	 Previous studies have reported that the G 2  phase cell cycle arrest induced by treatment with a [GENE] [EXPE] or DNA-damaging reagents caused precocious centriole disengagement   Prosser et al 2012 ;  Douthwright and Sluder 2014   
2021	PMC7836272	cep57	live-cell	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of [GENE] and Cep57L1 induces cell cycle arrest in interphase we performed a [EXPE] imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57	imaging	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of [GENE] and Cep57L1 induces cell cycle arrest in interphase we performed a live-cell [EXPE] analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57l1	live-cell	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of Cep57 and [GENE] induces cell cycle arrest in interphase we performed a [EXPE] imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57l1	imaging	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of Cep57 and [GENE] induces cell cycle arrest in interphase we performed a live-cell [EXPE] analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	poc5	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and POC5 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa-GFP-centrin1 cells were treated with siCep57/Cep57L1 and immunostained with antibodies against GFP (green), PCNT (red), and CENP-F (cyan).	 HeLa-GFP-centrin1 cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against GFP  green  [GENE]  red  and CENP-F  cyan  
2021	PMC7836272	plk1	inhibition	Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the inhibition of Plk1 perturbs centriole disengagement at the end of mitosis ( Tsou et al., 2009 ).	 Previous studies have reported that canonical centriole disengagement requires [GENE] activity and that the [EXPE] of Plk1 perturbs centriole disengagement at the end of mitosis   Tsou et al 2009   
2021	PMC7836272	plk1	inhibition	Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the inhibition of Plk1 perturbs centriole disengagement at the end of mitosis ( Tsou et al., 2009 ).	 Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the [EXPE] of [GENE] perturbs centriole disengagement at the end of mitosis   Tsou et al 2009   
2021	PMC7836272	plk1	inhibition	Precocious centriole disengagement in G 2 /M phase-arrested cells was also suppressed by Plk1 inhibition ( Prosser et al., 2012 ).	 Precocious centriole disengagement in G 2 /M phase-arrested cells was also suppressed by [GENE] [EXPE]   Prosser et al 2012   
2021	PMC7836272	plk1	inhibitor	To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity, we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule inhibitor of Plk1 (BI2536).	 To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires [GENE] activity we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule [EXPE] of Plk1  BI2536  
2021	PMC7836272	plk1	inhibitor	To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity, we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule inhibitor of Plk1 (BI2536).	 To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule [EXPE] of [GENE]  BI2536  
2021	PMC7836272	plk1	inhibition	Inhibition of Plk1 prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement.	 [EXPE] of [GENE] prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement 
2021	PMC7836272	plk1	suppress	Inhibition of Plk1 prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement.	 Inhibition of [GENE] prevents disengaged daughter centrioles from acquiring PCM but does not [EXPE] precocious centriole disengagement 
2021	PMC7836272	cdk1	immunostained	HeLa cells were synchronized in the G 1 /S phase by aphidicolin (1.2 µg/ml) for 17 h, then released into fresh medium for 4 h. Next, the cells were treated with DMSO (control), RO3306 (Cdk1 inhibitor; 10 µM), or both of RO3306 and BI2536 (100 nM) for 24 h. HeLa cells were immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were synchronized in the G 1 /S phase by aphidicolin  12 µg/ml  for 17 h then released into fresh medium for 4 h Next the cells were treated with DMSO  control  RO3306  [GENE] inhibitor; 10 µM  or both of RO3306 and BI2536  100 nM  for 24 h HeLa cells were [EXPE] with antibodies against centrin  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were synchronized in the G 1 /S phase by aphidicolin (1.2 µg/ml) for 17 h, then released into fresh medium for 4 h. Next, the cells were treated with DMSO (control), RO3306 (Cdk1 inhibitor; 10 µM), or both of RO3306 and BI2536 (100 nM) for 24 h. HeLa cells were immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were synchronized in the G 1 /S phase by aphidicolin  12 µg/ml  for 17 h then released into fresh medium for 4 h Next the cells were treated with DMSO  control  RO3306  Cdk1 inhibitor; 10 µM  or both of RO3306 and BI2536  100 nM  for 24 h HeLa cells were [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa-GFP-centrin1 cells were treated as in C and immunostained with antibodies against GFP (green), CENP-F (red), and PCNT (cyan).	 HeLa-GFP-centrin1 cells were treated as in C and [EXPE] with antibodies against GFP  green  CENP-F  red  and [GENE]  cyan  
2021	PMC7836272	cep57l1	immunostained	To do this, we immunostained HeLa cells with an antibody against Cep57L1 and found that endogenous Cep57L1 localized at mother centrioles ( Fig. 5 A ).	 To do this we [EXPE] HeLa cells with an antibody against [GENE] and found that endogenous Cep57L1 localized at mother centrioles   Fig 5 A   
2021	PMC7836272	cep57l1	immunostained	To do this, we immunostained HeLa cells with an antibody against Cep57L1 and found that endogenous Cep57L1 localized at mother centrioles ( Fig. 5 A ).	 To do this we [EXPE] HeLa cells with an antibody against Cep57L1 and found that endogenous [GENE] localized at mother centrioles   Fig 5 A   
2021	PMC7836272	cep57l1	depletion	Moreover, stimulated emission depletion (STED) analysis showed that Cep57L1 formed a ring-like structure around the mother centriole ( Fig. 5 B ).	 Moreover stimulated emission [EXPE]  STED  analysis showed that [GENE] formed a ring-like structure around the mother centriole   Fig 5 B   
2021	PMC7836272	cep57l1	sted	Moreover, stimulated emission depletion (STED) analysis showed that Cep57L1 formed a ring-like structure around the mother centriole ( Fig. 5 B ).	 Moreover stimulated emission depletion  [EXPE]  analysis showed that [GENE] formed a ring-like structure around the mother centriole   Fig 5 B   
2021	PMC7836272	cep57	sted	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 [EXPE] microscopy also revealed the colocalization of [GENE] and Cep57L1 around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57	microscopy	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 STED [EXPE] also revealed the colocalization of [GENE] and Cep57L1 around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	sted	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 [EXPE] microscopy also revealed the colocalization of Cep57 and [GENE] around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	microscopy	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 STED [EXPE] also revealed the colocalization of Cep57 and [GENE] around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	sirna	The specificity of the antibody was validated using siRNA against Cep57L1 ( Fig. 5 C ).	 The specificity of the antibody was validated using [EXPE] against [GENE]   Fig 5 C   
2021	PMC7836272	cep57	sted	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using [EXPE] microscopy we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57	microscopy	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED [EXPE] we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57	sirna	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED microscopy we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal [EXPE] treatment 
2021	PMC7836272	cep57l1	sted	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using [EXPE] microscopy we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57l1	microscopy	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED [EXPE] we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57l1	sirna	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED microscopy we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal [EXPE] treatment 
2021	PMC7836272	cep57	depletion	Depletion of Cep57 or Cep57L1 did not significantly affect each other’s localization pattern at centrioles ( Fig. 5 C ;  Fig. S3, F and G ).	 [EXPE] of [GENE] or Cep57L1 did not significantly affect each other’s localization pattern at centrioles   Fig 5 C ;  Fig S3 F and G   
2021	PMC7836272	cep57l1	depletion	Depletion of Cep57 or Cep57L1 did not significantly affect each other’s localization pattern at centrioles ( Fig. 5 C ;  Fig. S3, F and G ).	 [EXPE] of Cep57 or [GENE] did not significantly affect each other’s localization pattern at centrioles   Fig 5 C ;  Fig S3 F and G   
2021	PMC7836272	cep57l1	immunostained	HeLa cells were immunostained with antibodies against Cep57L1 (red) and centrin (green).	 HeLa cells were [EXPE] with antibodies against [GENE]  red  and centrin  green  
2021	PMC7836272	pcnt	sted	 (B)  STED images representing top view of Cep57/Cep57L1 (red) and PCNT (green) at mother centrioles.	   B   [EXPE] images representing top view of Cep57/Cep57L1  red  and [GENE]  green  at mother centrioles 
2021	PMC7836272	cep57	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  Cep57  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  Cep57  red  and [GENE]  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep57l1	sted	 (E)  STED images representing top view of Cep57L1 (red) and Cep57 (green) at mother centrioles.	   E   [EXPE] images representing top view of [GENE]  red  and Cep57  green  at mother centrioles 
2021	PMC7836272	cep57	sted	 (E)  STED images representing top view of Cep57L1 (red) and Cep57 (green) at mother centrioles.	   E   [EXPE] images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles 
2021	PMC7836272	cep57	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon siRNA treatment against Cep57L1 
2021	PMC7836272	cep57	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against Cep57L1 
2021	PMC7836272	pcnt	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of Cep57  red  and [GENE]  green  at mother centrioles upon siRNA treatment against Cep57L1 
2021	PMC7836272	pcnt	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of Cep57  red  and [GENE]  green  at mother centrioles upon [EXPE] treatment against Cep57L1 
2021	PMC7836272	cep57l1	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of Cep57  red  and PCNT  green  at mother centrioles upon siRNA treatment against [GENE] 
2021	PMC7836272	cep57l1	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of Cep57  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against [GENE] 
2021	PMC7836272	cep57l1	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon siRNA treatment against Cep57 
2021	PMC7836272	cep57l1	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against Cep57 
2021	PMC7836272	pcnt	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles upon siRNA treatment against Cep57 
2021	PMC7836272	pcnt	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles upon [EXPE] treatment against Cep57 
2021	PMC7836272	cep57	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of Cep57L1  red  and PCNT  green  at mother centrioles upon siRNA treatment against [GENE] 
2021	PMC7836272	cep57	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of Cep57L1  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against [GENE] 
2021	PMC7836272	cep57	depletion	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by [GENE] [EXPE] was not rescued by exogenous expression of Cep57L1 
2021	PMC7836272	cep57	rescued	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by [GENE] depletion was not [EXPE] by exogenous expression of Cep57L1 
2021	PMC7836272	cep57l1	depletion	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by Cep57 [EXPE] was not rescued by exogenous expression of [GENE] 
2021	PMC7836272	cep57l1	rescued	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by Cep57 depletion was not [EXPE] by exogenous expression of [GENE] 
2021	PMC7836272	cep57l1	coimmunoprecipitation	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and [EXPE]  co-IP  analyses with the mutant revealed that the PINC motif of [GENE] was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the PCNT C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	cep57l1	co-ip	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and coimmunoprecipitation  [EXPE]  analyses with the mutant revealed that the PINC motif of [GENE] was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the PCNT C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	pcnt	coimmunoprecipitation	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and [EXPE]  co-IP  analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the [GENE] C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	pcnt	co-ip	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and coimmunoprecipitation  [EXPE]  analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the [GENE] C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	cep57	pfam	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the [EXPE] protein family database predicted the presence of microtubule-binding domains in both [GENE] and Cep57L1   Fig S1 A   
2021	PMC7836272	cep57	database	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the Pfam protein family [EXPE] predicted the presence of microtubule-binding domains in both [GENE] and Cep57L1   Fig S1 A   
2021	PMC7836272	cep57l1	pfam	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the [EXPE] protein family database predicted the presence of microtubule-binding domains in both Cep57 and [GENE]   Fig S1 A   
2021	PMC7836272	cep57l1	database	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the Pfam protein family [EXPE] predicted the presence of microtubule-binding domains in both Cep57 and [GENE]   Fig S1 A   
2021	PMC7836272	cep57	overexpressed	As previously reported, overexpressed Cep57 was occasionally localized on the microtubule network via its microtubule-binding domain ( Fig. S4 C ;  Momotani et al., 2008 ).	 As previously reported [EXPE] [GENE] was occasionally localized on the microtubule network via its microtubule-binding domain   Fig S4 C ;  Momotani et al 2008   
2021	PMC7836272	cep57l1	overexpressed	In contrast, overexpressed Cep57L1 did not show such a localization pattern, but instead aggregated in the cytoplasm ( Fig. S4 C ).	 In contrast [EXPE] [GENE] did not show such a localization pattern but instead aggregated in the cytoplasm   Fig S4 C   
2021	PMC7836272	cep57	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of [GENE] and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of [GENE] and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and [GENE] proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and [GENE] proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of [GENE] but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of [GENE] but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of [GENE]   Fig S4 D   
2021	PMC7836272	cep57	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of [GENE]   Fig S4 D   
2021	PMC7836272	cep192	immunostained	HeLa cells expressing FLAG-Cep57L1 or FLAG-Cep57L1 mutant lacking the PINC motif (Δ52–86 aa) were immunostained with antibodies against FLAG (green) and Cep192 (red).	 HeLa cells expressing FLAG-Cep57L1 or FLAG-Cep57L1 mutant lacking the PINC motif  Δ52–86 aa  were [EXPE] with antibodies against FLAG  green  and [GENE]  red  
2021	PMC7836272	cep57	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   [EXPE] [GENE] was accumulated on the microtubules but overexpressed Cep57L1 aggregated in the cytoplasm 
2021	PMC7836272	cep57	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   Overexpressed [GENE] was accumulated on the microtubules but [EXPE] Cep57L1 aggregated in the cytoplasm 
2021	PMC7836272	cep57l1	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   [EXPE] Cep57 was accumulated on the microtubules but overexpressed [GENE] aggregated in the cytoplasm 
2021	PMC7836272	cep57l1	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   Overexpressed Cep57 was accumulated on the microtubules but [EXPE] [GENE] aggregated in the cytoplasm 
2021	PMC7836272	cep152	depletion	 (E)  Depletion of Cep152 has a modest effect on centriole duplication.	   E   [EXPE] of [GENE] has a modest effect on centriole duplication 
2021	PMC7836272	cep152	sirnas	 (F)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   F   Beeswarm plots piled on boxplots represent the normalized signal intensity of [GENE] at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  CP110  red  and [GENE]  cyan  
2021	PMC7836272	cep63	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that [GENE]  median 306% compared with siControl;  n  > 50  or Cep152 [EXPE]  193%  significantly decreased the signal intensity of Cep57 at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that Cep63  median 306% compared with siControl;  n  > 50  or [GENE] [EXPE]  193%  significantly decreased the signal intensity of Cep57 at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep57	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that Cep63  median 306% compared with siControl;  n  > 50  or Cep152 [EXPE]  193%  significantly decreased the signal intensity of [GENE] at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of [GENE]  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or [GENE]  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57l1	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of [GENE] at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both [GENE] and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57l1	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and [GENE] localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on [GENE] and Cep152   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and [GENE]   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of [GENE] and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and [GENE] at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of [GENE]  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  [GENE] 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; [GENE] 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57l1	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or [GENE]  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  [GENE] 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; [GENE] 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of [GENE] and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57l1	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and [GENE] reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of [GENE] at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	Moreover, as reported in previous studies ( Lukinavičius et al., 2013 ;  Kim et al., 2019 ;  Brown et al., 2013 ), the signal intensity of Cep152 was attenuated by Cep63 depletion (25.8%) and vice versa (66.4%;  Fig. 6 D ).	 Moreover as reported in previous studies   Lukinavičius et al 2013 ;  Kim et al 2019 ;  Brown et al 2013   the signal intensity of [GENE] was attenuated by Cep63 [EXPE]  258%  and vice versa  664%;  Fig 6 D   
2021	PMC7836272	cep63	depletion	Moreover, as reported in previous studies ( Lukinavičius et al., 2013 ;  Kim et al., 2019 ;  Brown et al., 2013 ), the signal intensity of Cep152 was attenuated by Cep63 depletion (25.8%) and vice versa (66.4%;  Fig. 6 D ).	 Moreover as reported in previous studies   Lukinavičius et al 2013 ;  Kim et al 2019 ;  Brown et al 2013   the signal intensity of Cep152 was attenuated by [GENE] [EXPE]  258%  and vice versa  664%;  Fig 6 D   
2021	PMC7836272	cep57	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  Cep63  red  and GT335  cyan  
2021	PMC7836272	cep63	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against ODF2  green  [GENE]  red  and GT335  cyan  
2021	PMC7836272	gt335	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against ODF2  green  Cep63  red  and [GENE]  cyan  
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against [GENE]  green  Cep152  red  and GT335  cyan  
2021	PMC7836272	cep152	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against ODF2  green  [GENE]  red  and GT335  cyan  
2021	PMC7836272	gt335	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against ODF2  green  Cep152  red  and [GENE]  cyan  
2021	PMC7836272	cep57	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of [GENE] Cep57L1 Cep63 and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep57l1	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 [GENE] Cep63 and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep63	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 Cep57L1 [GENE] and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep152	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 Cep57L1 Cep63 and [GENE] at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep57	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of [GENE] and Cep57L1 did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep57l1	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of Cep57 and [GENE] did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 for 96 h and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57/Cep57L1 for 96 h and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57l1	depletion	Note that depletion of Cep57L1 for 96 h slightly reduced the number of centrioles.	 Note that [EXPE] of [GENE] for 96 h slightly reduced the number of centrioles 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  and [GENE]  red  
2021	PMC7836272	cep57	depletion	Single depletion of Cep57 caused precocious centriole disengagement only in mitosis, but not in interphase (pattern 2;  Fig. 8, A and B ).	 Single [EXPE] of [GENE] caused precocious centriole disengagement only in mitosis but not in interphase  pattern 2;  Fig 8 A and B   
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of [GENE] and Cep57L1 did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep57l1	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of Cep57 and [GENE] did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 for 96 h and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57/Cep57L1 for 96 h and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57l1	depletion	Note that depletion of Cep57L1 for 96 h slightly reduced the number of centrioles.	 Note that [EXPE] of [GENE] for 96 h slightly reduced the number of centrioles 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  and [GENE]  red  
2019	PMC6389942	cep57	blast	To determine whether Cep57 is a conserved factor across species, we first performed BLAST analysis.	 To determine whether [GENE] is a conserved factor across species we first performed [EXPE] analysis 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against [GENE]  red  and GT335  green  and observed by STED microscopy 
2019	PMC6389942	cep57	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by [EXPE] microscopy 
2019	PMC6389942	cep57	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by STED [EXPE] 
2019	PMC6389942	gt335	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against Cep57  red  and [GENE]  green  and observed by STED microscopy 
2019	PMC6389942	gt335	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by [EXPE] microscopy 
2019	PMC6389942	gt335	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by STED [EXPE] 
2019	PMC6389942	cep57	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of [GENE] and Cep192 at mother centrioles 
2019	PMC6389942	cep192	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of Cep57 and [GENE] at mother centrioles 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and centrin-2.	 HeLa cells were [EXPE] with antibodies against [GENE] and centrin-2 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against [GENE] and PCNT 
2019	PMC6389942	pcnt	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against Cep57 and [GENE] 
2019	PMC6389942	cep192	transfection	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1μg) and Histone 2B-RFP (transfection control, 10ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1μg  and Histone 2B-RFP  [EXPE] control 10ng  were immunostained with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep192	immunostained	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1μg) and Histone 2B-RFP (transfection control, 10ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1μg  and Histone 2B-RFP  transfection control 10ng  were [EXPE] with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep57	immunofluorescence	Scale bar, 5μm in the low-magnified view, 1μm in the inset Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Scale bar 5μm in the low-magnified view 1μm in the inset Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an [EXPE] analysis with HeLa cells by using stimulated emission depletion  STED  microscopy 
2019	PMC6389942	cep57	depletion	Scale bar, 5μm in the low-magnified view, 1μm in the inset Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Scale bar 5μm in the low-magnified view 1μm in the inset Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission [EXPE]  STED  microscopy 
2019	PMC6389942	cep57	sted	Scale bar, 5μm in the low-magnified view, 1μm in the inset Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Scale bar 5μm in the low-magnified view 1μm in the inset Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion  [EXPE]  microscopy 
2019	PMC6389942	cep57	microscopy	Scale bar, 5μm in the low-magnified view, 1μm in the inset Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Scale bar 5μm in the low-magnified view 1μm in the inset Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion  STED  [EXPE] 
2019	PMC6389942	cep57	sted	STED analysis revealed that Cep57 formed ring-like structures around the proximal end of the mother centriole wall across the cell cycle (Fig. 1c ).	 [EXPE] analysis revealed that [GENE] formed ring-like structures around the proximal end of the mother centriole wall across the cell cycle  Fig 1c   
2019	PMC6389942	cep57	overexpressed	We also noted that overexpressed Cep57 occasionally localized to the filamentous microtubule network around the nucleus, which is consistent with previous reports 23 , 24  (Supplementary Fig. 1e ).	 We also noted that [EXPE] [GENE] occasionally localized to the filamentous microtubule network around the nucleus which is consistent with previous reports 23  24   Supplementary Fig 1e   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of [GENE] we next [EXPE] endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next [EXPE] endogenous [GENE] using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of Cep57 caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next [EXPE] endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7±3.8%, from three experiments) and precocious centriole disengagement (68.7±2.5%, from three experiments) in mitotic cells (Fig. 2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of [GENE] caused PCM disorganization  747±38% from three experiments  and precocious centriole disengagement  687±25% from three experiments  in mitotic cells  Fig 2a–c   
2019	PMC6389942	cep57	depletion	In contrast, depletion of Cep57 did not lead to any defects in centriolar recruitment of Cep152, centriole duplication, and PCM organization in interphase cells (Supplementary Fig. 2a–c ).	 In contrast [EXPE] of [GENE] did not lead to any defects in centriolar recruitment of Cep152 centriole duplication and PCM organization in interphase cells  Supplementary Fig 2a–c   
2019	PMC6389942	cep152	depletion	In contrast, depletion of Cep57 did not lead to any defects in centriolar recruitment of Cep152, centriole duplication, and PCM organization in interphase cells (Supplementary Fig. 2a–c ).	 In contrast [EXPE] of Cep57 did not lead to any defects in centriolar recruitment of [GENE] centriole duplication and PCM organization in interphase cells  Supplementary Fig 2a–c   
2019	PMC6389942	odf2	staining	To ensure the two centrioles seen at the poles are the mother and daughter centriole pair, we tested ODF2 staining which marks mother centrioles and found a single ODF2-positive focus out of two separate centrioles at a spindle pole in Cep57-depleted cells (Supplementary Fig. 2d ).	 To ensure the two centrioles seen at the poles are the mother and daughter centriole pair we tested [GENE] [EXPE] which marks mother centrioles and found a single ODF2-positive focus out of two separate centrioles at a spindle pole in Cep57-depleted cells  Supplementary Fig 2d   
2019	PMC6389942	cep57	sirnas	The same mitotic defects were observed in different human cell lines (Supplementary Fig. 2e ) or when using siRNAs targeting different sequences of Cep57 ORF (Supplementary Fig. 2f ).	 The same mitotic defects were observed in different human cell lines  Supplementary Fig 2e   or when using [EXPE] targeting different sequences of [GENE] ORF  Supplementary Fig 2f   
2019	PMC6389942	cep57	sirna	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig. 2g ).	 The efficacy of [GENE] [EXPE] was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57  Supplementary Fig 2g   
2019	PMC6389942	cep57	immunofluorescence	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig. 2g ).	 The efficacy of [GENE] siRNA was confirmed using [EXPE] analysis with specific antibodies against endogenous Cep57  Supplementary Fig 2g   
2019	PMC6389942	cep57	sirna	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig. 2g ).	 The efficacy of Cep57 [EXPE] was confirmed using immunofluorescence analysis with specific antibodies against endogenous [GENE]  Supplementary Fig 2g   
2019	PMC6389942	cep57	immunofluorescence	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig. 2g ).	 The efficacy of Cep57 siRNA was confirmed using [EXPE] analysis with specific antibodies against endogenous [GENE]  Supplementary Fig 2g   
2019	PMC6389942	cep57	rescued	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were [EXPE] by expressing RNAi-resistant full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA  Supplementary Fig 3a b   
2019	PMC6389942	cep57	rnai-resistant	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were rescued by expressing [EXPE] full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA  Supplementary Fig 3a b   
2019	PMC6389942	cep57	sirna	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were rescued by expressing RNAi-resistant full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 [EXPE]  Supplementary Fig 3a b   
2019	PMC6389942	cep57	rescued	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were [EXPE] by expressing RNAi-resistant full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] siRNA  Supplementary Fig 3a b   
2019	PMC6389942	cep57	rnai-resistant	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were rescued by expressing [EXPE] full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] siRNA  Supplementary Fig 3a b   
2019	PMC6389942	cep57	sirna	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig. 3a, b ).	 Furthermore these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] [EXPE]  Supplementary Fig 3a b   
2019	PMC6389942	cep57	depletion	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon [EXPE] of [GENE] we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	live imaging	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon depletion of [GENE] we also performed a [EXPE] of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	imaging	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon depletion of [GENE] we also performed a live [EXPE] of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	depletion	These data suggest that Cep57 is critical for PCM integrity and centriole engagement, and also that ectopic MTOC activity of disengaged daughter centrioles, provoked by Cep57 depletion, may be deleterious to cells.	 These data suggest that [GENE] is critical for PCM integrity and centriole engagement and also that ectopic MTOC activity of disengaged daughter centrioles provoked by Cep57 [EXPE] may be deleterious to cells 
2019	PMC6389942	cep57	depletion	These data suggest that Cep57 is critical for PCM integrity and centriole engagement, and also that ectopic MTOC activity of disengaged daughter centrioles, provoked by Cep57 depletion, may be deleterious to cells.	 These data suggest that Cep57 is critical for PCM integrity and centriole engagement and also that ectopic MTOC activity of disengaged daughter centrioles provoked by [GENE] [EXPE] may be deleterious to cells 
2019	PMC6389942	cep192	immunostained	 a  HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against centrin-2 (green) and Cep192 (red).	  a  HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 b  Schematic model of the phenotype of Cep57 knockdown observed in  a .	  b  Schematic model of the phenotype of [GENE] [EXPE] observed in  a  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 led to PCM disorganization and precocious centriole disengagement.	 [EXPE] of [GENE] led to PCM disorganization and precocious centriole disengagement 
2019	PMC6389942	cep57	time-lapse	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  [EXPE] observation of cells upon [GENE] depletion 
2019	PMC6389942	cep57	depletion	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  Time-lapse observation of cells upon [GENE] [EXPE] 
2019	PMC6389942	cp110	immunostained	HeLa cells were immunostained with antibodies against α-Tubulin (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against α-Tubulin  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 i  Schematic illustration of the phenotype of Cep57 knockdown observed in  g  and  h .	  i  Schematic illustration of the phenotype of [GENE] [EXPE] observed in  g  and  h  
2019	PMC6389942	cep57	depletion	** p <0.01 Given the above, we next examined the impact of Cep57 depletion on chromosome segregation in HeLa cells.	 ** p <001 Given the above we next examined the impact of [GENE] [EXPE] on chromosome segregation in HeLa cells 
2019	PMC6389942	cep57	depletion	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig. 4c ).	 Moreover chromosome misalignment one of the major defects provoked by [GENE] [EXPE] was efficiently rescued by the expression of Cep57  Supplementary Fig 4c   
2019	PMC6389942	cep57	rescued	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig. 4c ).	 Moreover chromosome misalignment one of the major defects provoked by [GENE] depletion was efficiently [EXPE] by the expression of Cep57  Supplementary Fig 4c   
2019	PMC6389942	cep57	depletion	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig. 4c ).	 Moreover chromosome misalignment one of the major defects provoked by Cep57 [EXPE] was efficiently rescued by the expression of [GENE]  Supplementary Fig 4c   
2019	PMC6389942	cep57	rescued	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig. 4c ).	 Moreover chromosome misalignment one of the major defects provoked by Cep57 depletion was efficiently [EXPE] by the expression of [GENE]  Supplementary Fig 4c   
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 [EXPE] of [GENE] or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 [EXPE] of Cep57 or  [GENE]  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep192	immunostained	MVA patients’ lymphoblastoid cell lines (LCLs) and their mother’s LCL (unaffected control) were immunostained with antibodies against centrin-2 (green) and Cep192 (red).	 MVA patients’ lymphoblastoid cell lines  LCLs  and their mother’s LCL  unaffected control  were [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of [GENE] or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of Cep57 or  [GENE]  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	** p <0.01; NS not significantly different ( p >0.05) A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint (SAC) and also that depletion of Cep57 causes an impairment of SAC function, and resulting premature onset of anaphase 21 .	 ** p <001; NS not significantly different   p >005  A previous report showed that kinetochore-localized [GENE] is involved in spindle assembly checkpoint  SAC  and also that [EXPE] of Cep57 causes an impairment of SAC function and resulting premature onset of anaphase 21  
2019	PMC6389942	cep57	depletion	** p <0.01; NS not significantly different ( p >0.05) A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint (SAC) and also that depletion of Cep57 causes an impairment of SAC function, and resulting premature onset of anaphase 21 .	 ** p <001; NS not significantly different   p >005  A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint  SAC  and also that [EXPE] of [GENE] causes an impairment of SAC function and resulting premature onset of anaphase 21  
2019	PMC6389942	cep57	depletion	To judge whether such SAC impairment could cause chromosomal segregation errors, we quantified the time from nuclear envelope breakdown to anaphase onset (AO) upon depletion of Cep57.	 To judge whether such SAC impairment could cause chromosomal segregation errors we quantified the time from nuclear envelope breakdown to anaphase onset  AO  upon [EXPE] of [GENE] 
2019	PMC6389942	cep57	depletion	We found that depletion of Cep57 did not decrease mitotic duration, compared to the control cells, whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration (Supplementary Fig. 4f ).	 We found that [EXPE] of [GENE] did not decrease mitotic duration compared to the control cells whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration  Supplementary Fig 4f   
2019	PMC6389942	cep57	depletion	We found that depletion of Cep57 did not decrease mitotic duration, compared to the control cells, whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration (Supplementary Fig. 4f ).	 We found that depletion of [GENE] did not decrease mitotic duration compared to the control cells whereas [EXPE] of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration  Supplementary Fig 4f   
2019	PMC6389942	cep57	depletion	Moreover, depletion of Cep57 did not reduce the kinetochore signal of Mad1 in HeLa cells treated with nocodazole and MG132 (Supplementary Fig. 4g, h ).	 Moreover [EXPE] of [GENE] did not reduce the kinetochore signal of Mad1 in HeLa cells treated with nocodazole and MG132  Supplementary Fig 4g h   
2019	PMC6389942	cep57	depletion	We therefore reasoned that chromosomal segregation errors caused by Cep57 depletion in this condition are due to precocious centriole disengagement and PCM disorganization, rather than reduced SAC signaling.	 We therefore reasoned that chromosomal segregation errors caused by [GENE] [EXPE] in this condition are due to precocious centriole disengagement and PCM disorganization rather than reduced SAC signaling 
2019	PMC6389942	cep57	depletion	Overall, these findings strongly suggest that both Cep57 depletion and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis, which results in chromosomal segregation errors and aneuploidy (Fig. 3i ).	 Overall these findings strongly suggest that both [GENE] [EXPE] and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis which results in chromosomal segregation errors and aneuploidy  Fig 3i   
2019	PMC6389942	cep57	depletion	Overall, these findings strongly suggest that both Cep57 depletion and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis, which results in chromosomal segregation errors and aneuploidy (Fig. 3i ).	 Overall these findings strongly suggest that both Cep57 [EXPE] and  [GENE]  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis which results in chromosomal segregation errors and aneuploidy  Fig 3i   
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig. 6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of [GENE] a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig 6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	separase	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig. 6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by [GENE] is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig 6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig. 6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of [GENE] only caused precocious centriole disengagement in early mitosis  Supplementary Fig 6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	cep57	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig. 6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig 6a b   we examined whether [GENE] physically interacts with PCNT 
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig. 6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig 6a b   we examined whether Cep57 physically interacts with [GENE] 
2019	PMC6389942	cep57	co-ip	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using [EXPE] assay with deletion constructs of [GENE] we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	assay	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using co-IP [EXPE] with deletion constructs of [GENE] we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	co-ip	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using [EXPE] assay with deletion constructs of Cep57 we narrowed down the [GENE] region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	assay	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using co-IP [EXPE] with deletion constructs of Cep57 we narrowed down the [GENE] region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	pcnt	co-ip	First, by using co-IP analyses with PCNT truncate mutants, we found	 First by using [EXPE] analyses with [GENE] truncate mutants we found 
2019	PMC6389942	akap9	co-ip	Co-IP analysis with the AKAP9 C-terminus (a.a.	 [EXPE] analysis with the [GENE] C-terminus  aa 
2019	PMC6389942	cep57	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially [EXPE] recombinant proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	recombinant	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified [EXPE] proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we [EXPE] [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	co-ip	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by [EXPE] experiments 
2019	PMC6389942	pcnt	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially [EXPE] recombinant proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	recombinant	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified [EXPE] proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we [EXPE] Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	co-ip	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by [EXPE] experiments 
2019	PMC6389942	cep57	pull-down	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig. 4f , Supplementary Fig. 6d ).	 We demonstrated that the two proteins interacted with each other by [EXPE] assays suggesting the physical association between [GENE] and PCNT  Fig 4f  Supplementary Fig 6d   
2019	PMC6389942	cep57	assays	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig. 4f , Supplementary Fig. 6d ).	 We demonstrated that the two proteins interacted with each other by pull-down [EXPE] suggesting the physical association between [GENE] and PCNT  Fig 4f  Supplementary Fig 6d   
2019	PMC6389942	pcnt	pull-down	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig. 4f , Supplementary Fig. 6d ).	 We demonstrated that the two proteins interacted with each other by [EXPE] assays suggesting the physical association between Cep57 and [GENE]  Fig 4f  Supplementary Fig 6d   
2019	PMC6389942	pcnt	assays	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig. 4f , Supplementary Fig. 6d ).	 We demonstrated that the two proteins interacted with each other by pull-down [EXPE] suggesting the physical association between Cep57 and [GENE]  Fig 4f  Supplementary Fig 6d   
2019	PMC6389942	pcnt	recombinant	We noted that the C-terminus PCNT recombinant protein lacking the region of a.a.	 We noted that the C-terminus [GENE] [EXPE] protein lacking the region of aa 
2019	PMC6389942	cep57	pull-down	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig. 6e ).	 [EXPE] assays also showed the direct interaction between [GENE] and AKAP9  Supplementary Fig 6e   
2019	PMC6389942	cep57	assays	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig. 6e ).	 Pull-down [EXPE] also showed the direct interaction between [GENE] and AKAP9  Supplementary Fig 6e   
2019	PMC6389942	akap9	pull-down	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig. 6e ).	 [EXPE] assays also showed the direct interaction between Cep57 and [GENE]  Supplementary Fig 6e   
2019	PMC6389942	akap9	assays	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig. 6e ).	 Pull-down [EXPE] also showed the direct interaction between Cep57 and [GENE]  Supplementary Fig 6e   
2019	PMC6389942	cep57	co-expressed	Third, to test whether Cep57 is a target of the PACT domain, we co-expressed HA-Cep57 and the GFP-PCNT C-terminus (a.a. 3113–3336) containing the PACT domain in human cells.	 Third to test whether [GENE] is a target of the PACT domain we [EXPE] HA-Cep57 and the GFP-PCNT C-terminus  aa 3113–3336  containing the PACT domain in human cells 
2019	PMC6389942	cep57	co-expressed	In contrast, when the GFP-PCNT C-terminus was co-expressed with HA-Cep57, GFP-PCNT C-terminus co-localized with overexpressed Cep57 on microtubules as well as at centrioles (Fig. 4g ).	 In contrast when the GFP-PCNT C-terminus was [EXPE] with HA-Cep57 GFP-PCNT C-terminus co-localized with overexpressed [GENE] on microtubules as well as at centrioles  Fig 4g   
2019	PMC6389942	cep57	overexpressed	In contrast, when the GFP-PCNT C-terminus was co-expressed with HA-Cep57, GFP-PCNT C-terminus co-localized with overexpressed Cep57 on microtubules as well as at centrioles (Fig. 4g ).	 In contrast when the GFP-PCNT C-terminus was co-expressed with HA-Cep57 GFP-PCNT C-terminus co-localized with [EXPE] [GENE] on microtubules as well as at centrioles  Fig 4g   
2019	PMC6389942	pcnt	overexpressed	These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to overexpressed Cep57 that ectopically localizes to the microtubule network.	 These data suggest that the [GENE] PACT domain is loaded onto microtubules due to its binding to [EXPE] Cep57 that ectopically localizes to the microtubule network 
2019	PMC6389942	cep57	overexpressed	These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to overexpressed Cep57 that ectopically localizes to the microtubule network.	 These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to [EXPE] [GENE] that ectopically localizes to the microtubule network 
2019	PMC6389942	cep57	overexpressed	3643–3907) also co-localized with overexpressed Cep57 on microtubules (Fig. 4g ).	 3643–3907  also co-localized with [EXPE] [GENE] on microtubules  Fig 4g   
2019	PMC6389942	cep57	sted	Finally, we performed STED analysis to precisely test the co-localization of Cep57 and PCNT around centrioles.	 Finally we performed [EXPE] analysis to precisely test the co-localization of [GENE] and PCNT around centrioles 
2019	PMC6389942	pcnt	sted	Finally, we performed STED analysis to precisely test the co-localization of Cep57 and PCNT around centrioles.	 Finally we performed [EXPE] analysis to precisely test the co-localization of Cep57 and [GENE] around centrioles 
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig. 6g ).	 [EXPE] analysis with N- and C-terminal [GENE] antibodies showed that Cep57 co-localized with the C-terminus of PCNT but not with the N-terminus of PCNT in interphase  Supplementary Fig 6g   
2019	PMC6389942	cep57	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig. 6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that [GENE] co-localized with the C-terminus of PCNT but not with the N-terminus of PCNT in interphase  Supplementary Fig 6g   
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig. 6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of [GENE] but not with the N-terminus of PCNT in interphase  Supplementary Fig 6g   
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig. 6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT but not with the N-terminus of [GENE] in interphase  Supplementary Fig 6g   
2019	PMC6389942	cep57	co-ip	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	cep57	assays	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	co-ip	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	cep57	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	cep57	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	pcnt	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	pcnt	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	cep57	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  [GENE]  red  and Cep192  cyan  
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  Cep57  red  and [GENE]  cyan  
2019	PMC6389942	pcnt	co-ip	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	transfection	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	pcnt	rnai-resistant	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE]  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	transfection	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	pcnt	rnai-resistant	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE] [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	cep57	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig. 8a, b ).	 Although we show that [GENE] is the direct interactor of the PACT domain of PCNT Cep57 [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig 8a b   
2019	PMC6389942	pcnt	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig. 8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of [GENE] Cep57 [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig 8a b   
2019	PMC6389942	cep57	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig. 8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of PCNT [GENE] [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig 8a b   
2019	PMC6389942	pcnt	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig. 8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of PCNT Cep57 [EXPE] slightly affected the loading of [GENE] in interphase  Supplementary Fig 8a b   
2019	PMC6389942	cep152	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig. 8d–f ).	 Importantly we found that [GENE] interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig 8d–f   
2019	PMC6389942	pcnt	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig. 8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of [GENE]  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig 8d–f   
2019	PMC6389942	cep152	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig. 8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of [GENE] significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig 8d–f   
2019	PMC6389942	pcnt	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig. 8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of [GENE] in interphase  Supplementary Fig 8d–f   
2019	PMC6389942	pcnt	overexpression	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig. 8e, f ).	 [EXPE] of CRISPR/Cas9-resistant GFP-Cep152 restored the [GENE] signal at centrioles in the same condition confirming the specificity of Cep152 guideRNA  Supplementary Fig 8e f   
2019	PMC6389942	pcnt	restored	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig. 8e, f ).	 Overexpression of CRISPR/Cas9-resistant GFP-Cep152 [EXPE] the [GENE] signal at centrioles in the same condition confirming the specificity of Cep152 guideRNA  Supplementary Fig 8e f   
2019	PMC6389942	cep152	overexpression	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig. 8e, f ).	 [EXPE] of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition confirming the specificity of [GENE] guideRNA  Supplementary Fig 8e f   
2019	PMC6389942	cep152	restored	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig. 8e, f ).	 Overexpression of CRISPR/Cas9-resistant GFP-Cep152 [EXPE] the PCNT signal at centrioles in the same condition confirming the specificity of [GENE] guideRNA  Supplementary Fig 8e f   
2019	PMC6389942	pcnt	depleted	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we [EXPE] endogenous [GENE] using siRNA and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	sirna	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous [GENE] using [EXPE] and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	rnai-resistant	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous [GENE] using siRNA and expressed [EXPE]  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	depleted	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we [EXPE] endogenous PCNT using siRNA and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	sirna	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous PCNT using [EXPE] and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	rnai-resistant	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous PCNT using siRNA and expressed [EXPE]  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	depletion	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig. 5d, e ).	 Whereas [EXPE] of endogenous [GENE] caused precocious centriole disengagement in mitosis expression of the full-length PCNT functionally rescued this phenotype  Fig 5d e   
2019	PMC6389942	pcnt	rescued	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig. 5d, e ).	 Whereas depletion of endogenous [GENE] caused precocious centriole disengagement in mitosis expression of the full-length PCNT functionally [EXPE] this phenotype  Fig 5d e   
2019	PMC6389942	pcnt	depletion	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig. 5d, e ).	 Whereas [EXPE] of endogenous PCNT caused precocious centriole disengagement in mitosis expression of the full-length [GENE] functionally rescued this phenotype  Fig 5d e   
2019	PMC6389942	pcnt	rescued	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig. 5d, e ).	 Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis expression of the full-length [GENE] functionally [EXPE] this phenotype  Fig 5d e   
2019	PMC6389942	pcnt	rescue	In contrast, the two binding-deficient mutants failed to rescue the phenotype provoked by depletion of endogenous PCNT (Fig. 5d, e ).	 In contrast the two binding-deficient mutants failed to [EXPE] the phenotype provoked by depletion of endogenous [GENE]  Fig 5d e   
2019	PMC6389942	pcnt	depletion	In contrast, the two binding-deficient mutants failed to rescue the phenotype provoked by depletion of endogenous PCNT (Fig. 5d, e ).	 In contrast the two binding-deficient mutants failed to rescue the phenotype provoked by [EXPE] of endogenous [GENE]  Fig 5d e   
2019	PMC6389942	cep57	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig. 9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig. 9c, d ).	 In line with this notion we established that [EXPE] of [GENE] caused PCNT dispersion  Supplementary Fig 9b   and significantly shortened the height of PCNT that binds along the side of centriolar wall  Supplementary Fig 9c d   
2019	PMC6389942	pcnt	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig. 9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig. 9c, d ).	 In line with this notion we established that [EXPE] of Cep57 caused [GENE] dispersion  Supplementary Fig 9b   and significantly shortened the height of PCNT that binds along the side of centriolar wall  Supplementary Fig 9c d   
2019	PMC6389942	pcnt	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig. 9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig. 9c, d ).	 In line with this notion we established that [EXPE] of Cep57 caused PCNT dispersion  Supplementary Fig 9b   and significantly shortened the height of [GENE] that binds along the side of centriolar wall  Supplementary Fig 9c d   
2019	PMC6389942	cep57	rescue	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig. 9e ).	 As expected we demonstrated that expression of the [GENE] mutant did not [EXPE] the phenotype provoked by Cep57 depletion  Supplementary Fig 9e   
2019	PMC6389942	cep57	depletion	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig. 9e ).	 As expected we demonstrated that expression of the [GENE] mutant did not rescue the phenotype provoked by Cep57 [EXPE]  Supplementary Fig 9e   
2019	PMC6389942	cep57	rescue	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig. 9e ).	 As expected we demonstrated that expression of the Cep57 mutant did not [EXPE] the phenotype provoked by [GENE] depletion  Supplementary Fig 9e   
2019	PMC6389942	cep57	depletion	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig. 9e ).	 As expected we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by [GENE] [EXPE]  Supplementary Fig 9e   
2019	PMC6389942	pcnt	rescued	Interestingly, this chimera mutant efficiently rescued the disengagement phenotype of PCNT depletion (Fig. 5g, h ).	 Interestingly this chimera mutant efficiently [EXPE] the disengagement phenotype of [GENE] depletion  Fig 5g h   
2019	PMC6389942	pcnt	depletion	Interestingly, this chimera mutant efficiently rescued the disengagement phenotype of PCNT depletion (Fig. 5g, h ).	 Interestingly this chimera mutant efficiently rescued the disengagement phenotype of [GENE] [EXPE]  Fig 5g h   
2019	PMC6472344	plk4	purified	While performing in vitro biochemical experiments, we unexpectedly found that a kinase-dead (KD) mutant of a purified Plk4 fragment (Kinase+Linker 1) was highly insoluble compared with wild-type (WT) (Fig. 1a, b , Supplementary Fig. 1a ).	 While performing in vitro biochemical experiments we unexpectedly found that a kinase-dead  KD  mutant of a [EXPE] [GENE] fragment  Kinase+Linker 1  was highly insoluble compared with wild-type  WT   Fig 1a b  Supplementary Fig 1a   
2019	PMC6472344	plk4	purified	Source data are provided as a  Source Data  file To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig. 1d , Supplementary Fig. 1c  and  1d ).	 Source data are provided as a  Source Data  file To assess the solubility of [EXPE] [GENE] fragments in vitro we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig 1d  Supplementary Fig 1c  and  1d   
2019	PMC6472344	plk4	assay	Source data are provided as a  Source Data  file To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig. 1d , Supplementary Fig. 1c  and  1d ).	 Source data are provided as a  Source Data  file To assess the solubility of purified [GENE] fragments in vitro we performed a spin-down [EXPE] and showed that Plk4 WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig 1d  Supplementary Fig 1c  and  1d   
2019	PMC6472344	plk4	purified	Source data are provided as a  Source Data  file To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig. 1d , Supplementary Fig. 1c  and  1d ).	 Source data are provided as a  Source Data  file To assess the solubility of [EXPE] Plk4 fragments in vitro we performed a spin-down assay and showed that [GENE] WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig 1d  Supplementary Fig 1c  and  1d   
2019	PMC6472344	plk4	assay	Source data are provided as a  Source Data  file To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig. 1d , Supplementary Fig. 1c  and  1d ).	 Source data are provided as a  Source Data  file To assess the solubility of purified Plk4 fragments in vitro we performed a spin-down [EXPE] and showed that [GENE] WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig 1d  Supplementary Fig 1c  and  1d   
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize [GENE] self-assembly further we [EXPE] purified Plk4 fragments  Kinase+L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize [GENE] self-assembly further we visualized [EXPE] Plk4 fragments  Kinase+L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we [EXPE] purified [GENE] fragments  Kinase+L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we visualized [EXPE] [GENE] fragments  Kinase+L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we [EXPE] purified Plk4 fragments  Kinase+L1  and full-length [GENE] by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we visualized [EXPE] Plk4 fragments  Kinase+L1  and full-length [GENE] by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	overexpressed	We overexpressed the Plk4 (Kinase+L1) fragments in HeLa cells and found that depending on the degree of its expression level, the Plk4 fragments self-assemble into spherical structures (Fig. 2c , Supplementary Fig. 3a ).	 We [EXPE] the [GENE]  Kinase+L1  fragments in HeLa cells and found that depending on the degree of its expression level the Plk4 fragments self-assemble into spherical structures  Fig 2c  Supplementary Fig 3a   
2019	PMC6472344	plk4	overexpressed	We overexpressed the Plk4 (Kinase+L1) fragments in HeLa cells and found that depending on the degree of its expression level, the Plk4 fragments self-assemble into spherical structures (Fig. 2c , Supplementary Fig. 3a ).	 We [EXPE] the Plk4  Kinase+L1  fragments in HeLa cells and found that depending on the degree of its expression level the [GENE] fragments self-assemble into spherical structures  Fig 2c  Supplementary Fig 3a   
2019	PMC6472344	plk4	purified	Importantly, consistent with in vitro observation of the purified Plk4 proteins, expression of the kinase domain alone did not induce such structures, demonstrating the dependency on the L1 domain for self-condensation (Fig. 2c , Supplementary Fig. 3a ).	 Importantly consistent with in vitro observation of the [EXPE] [GENE] proteins expression of the kinase domain alone did not induce such structures demonstrating the dependency on the L1 domain for self-condensation  Fig 2c  Supplementary Fig 3a   
2019	PMC6472344	plk4	photobleaching	To reveal the significance of autophosphorylation for Plk4 condensation in cells, we performed fluorescence recovery after photobleaching (FRAP) analysis with HeLa cells expressing GFP-Plk4.	 To reveal the significance of autophosphorylation for [GENE] condensation in cells we performed fluorescence recovery after [EXPE]  FRAP  analysis with HeLa cells expressing GFP-Plk4 
2019	PMC6472344	plk4	frap	To reveal the significance of autophosphorylation for Plk4 condensation in cells, we performed fluorescence recovery after photobleaching (FRAP) analysis with HeLa cells expressing GFP-Plk4.	 To reveal the significance of autophosphorylation for [GENE] condensation in cells we performed fluorescence recovery after photobleaching  [EXPE]  analysis with HeLa cells expressing GFP-Plk4 
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that [EXPE] of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these [EXPE] similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that [EXPE] of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig 2e   although all of these [EXPE] similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that [EXPE] of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig. 2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig. 4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig 2e   although all of these [EXPE] similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig 4a   
2019	PMC6472344	plk4	inhibitor	Consistent with the effects of the inhibitor treatment, KD, 10A, and 13A mutations, but not 2A mutation (in the DSG phospho degron motif 16 , 20 ), attenuated Plk4 turnover both in the cytoplasmic condensates and at centrioles (Fig. 2g–i , Supplementary Fig. 4b  and  4c ).	 Consistent with the effects of the [EXPE] treatment KD 10A and 13A mutations but not 2A mutation  in the DSG phospho degron motif 16  20   attenuated [GENE] turnover both in the cytoplasmic condensates and at centrioles  Fig 2g–i  Supplementary Fig 4b  and  4c   
2019	PMC6472344	plk4	assay	We also confirmed the differences of condensation properties between Plk4 mutants using the plasma membrane tethering assay (Supplementary Fig. 5a–c ).	 We also confirmed the differences of condensation properties between [GENE] mutants using the plasma membrane tethering [EXPE]  Supplementary Fig 5a–c   
2019	PMC6472344	plk4	overexpression	In human cells, exogenous overexpression of Plk4 under a strong promoter such as CMV (cytomegalovirus) induces centriole overduplication 5 , 16 .	 In human cells exogenous [EXPE] of [GENE] under a strong promoter such as CMV  cytomegalovirus  induces centriole overduplication 5  16  
2019	PMC6472344	plk4	microscopy	Strikingly, structural illumination microscopy (SIM) revealed that even in cells with a ring-like distribution of Plk4, Plk4pS305 appeared as a single focus around mother centrioles (Fig.  4b ).	 Strikingly structural illumination [EXPE]  SIM  revealed that even in cells with a ring-like distribution of [GENE] Plk4pS305 appeared as a single focus around mother centrioles  Fig  4b   
2019	PMC6472344	plk4	sim	Strikingly, structural illumination microscopy (SIM) revealed that even in cells with a ring-like distribution of Plk4, Plk4pS305 appeared as a single focus around mother centrioles (Fig.  4b ).	 Strikingly structural illumination microscopy  [EXPE]  revealed that even in cells with a ring-like distribution of [GENE] Plk4pS305 appeared as a single focus around mother centrioles  Fig  4b   
2019	PMC6472344	stil	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig. 10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of [GENE] and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig 10b–e   further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4 
2019	PMC6472344	plk4	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig. 10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of STIL and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig 10b–e   further confirming that the occurrence of [GENE] phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4 
2019	PMC6472344	plk4	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig. 10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of STIL and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig 10b–e   further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of [GENE] 
2019	PMC6472344	cep152	costained	Cep152 was costained and used for a marker of mother centriole wall.	 [GENE] was [EXPE] and used for a marker of mother centriole wall 
2019	PMC6472344	cep152	3d-sim	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  [EXPE] images of centrioles immunostained with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	cep152	immunostained	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  3D-SIM images of centrioles [EXPE] with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig. 10e ).	 We also found that [EXPE] of [GENE] WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall  Supplementary Fig 10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig. 10e ).	 We also found that overexpression of [GENE] WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that Plk4 over-condensation induced by its [EXPE] promoted autonomous activation on the mother centriole wall  Supplementary Fig 10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig. 10e ).	 We also found that [EXPE] of Plk4 WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that [GENE] over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall  Supplementary Fig 10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig. 10e ).	 We also found that overexpression of Plk4 WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that [GENE] over-condensation induced by its [EXPE] promoted autonomous activation on the mother centriole wall  Supplementary Fig 10e   
2019	PMC6472344	plk4	inhibited	We first inhibited the kinase activity of Plk4 by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone (Fig. 5a ).	 We first [EXPE] the kinase activity of [GENE] by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone  Fig 5a   
2019	PMC6472344	plk4	inhibition	We first inhibited the kinase activity of Plk4 by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone (Fig. 5a ).	 We first inhibited the kinase activity of [GENE] by centrinone treatment in G1-arrested HeLa cells and subsequently released the [EXPE] by washout of centrinone  Fig 5a   
2019	PMC6472344	stil	depletion	In contrast, as reported previously 31 , depletion of HsSAS6 suppressed centriolar loading of STIL (Fig. 5c ).	 In contrast as reported previously 31  [EXPE] of HsSAS6 suppressed centriolar loading of [GENE]  Fig 5c   
2019	PMC6472344	stil	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   [GENE] and Plk4   c   in the indicated condition 
2019	PMC6472344	plk4	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   STIL and [GENE]   c   in the indicated condition 
2021	PMC7812875	cep192	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as [GENE] pericentrin and CDK5RAP2 and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	pericentrin	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as CEP192 [GENE] and CDK5RAP2 and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	cdk5rap2	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as CEP192 pericentrin and [GENE] and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	cep192	depletion	As previously described, the depletion of CEP192 caused severe defects in bipolar spindle formation and prolonged mitotic duration ( Fig. 1, A and B ;  Fig. S3 ;  Videos 1  and  2 ).	 As previously described the [EXPE] of [GENE] caused severe defects in bipolar spindle formation and prolonged mitotic duration   Fig 1 A and B ;  Fig S3 ;  Videos 1  and  2   
2021	PMC7812875	pericentrin	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double [EXPE] of [GENE] and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	pericentrin	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double depletion of [GENE] and CDK5RAP2 or their individual [EXPE] had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double [EXPE] of pericentrin and [GENE] or their individual depletion had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double depletion of pericentrin and [GENE] or their individual [EXPE] had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cep192	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of [GENE] at centrosomes upon [EXPE] of pericentrin and CDK5RAP2 
2021	PMC7812875	pericentrin	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of CEP192 at centrosomes upon [EXPE] of [GENE] and CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of CEP192 at centrosomes upon [EXPE] of pericentrin and [GENE] 
2021	PMC7812875	cep192	depletion	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission [EXPE]  STED  microscopy to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	sted	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission depletion  [EXPE]  microscopy to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	microscopy	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission depletion  STED  [EXPE] to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	sted	STED images showing centriolar distribution of CEP192 in pericentrin/CDK5RAP2 double-depleted cells.	 [EXPE] images showing centriolar distribution of [GENE] in pericentrin/CDK5RAP2 double-depleted cells 
2021	PMC7812875	cep192	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cep192	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cep192	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	cep192	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	cdk5rap2	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	pericentrin	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	pericentrin	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	pericentrin	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	pericentrin	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	cep192	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal [GENE]  D  CDK5RAP2  E  and pericentrin  F  
2021	PMC7812875	cdk5rap2	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal CEP192  D  [GENE]  E  and pericentrin  F  
2021	PMC7812875	pericentrin	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal CEP192  D  CDK5RAP2  E  and [GENE]  F  
2021	PMC7812875	plk4	inhibitors	To understand the functions of PCM independently of centrioles in human cells, we next induced the formation of mitotic spindles with one or zero centrosomes by treating HeLa cells with the PLK4 inhibitors centrinone or centrinone B ( Fig. 2, A and B ).	 To understand the functions of PCM independently of centrioles in human cells we next induced the formation of mitotic spindles with one or zero centrosomes by treating HeLa cells with the [GENE] [EXPE] centrinone or centrinone B   Fig 2 A and B   
2021	PMC7812875	cep192	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	cep192	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	cep192	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	pericentrin	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	pericentrin	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	pericentrin	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	cdk5rap2	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	cdk5rap2	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	cdk5rap2	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	cep192	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of [GENE] but not pericentrin or CDK5RAP2 prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	pericentrin	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of CEP192 but not [GENE] or CDK5RAP2 prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	cdk5rap2	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of CEP192 but not pericentrin or [GENE] prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	pericentrin	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of [GENE] or CDK5RAP2 as well as CEP192 significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of pericentrin or [GENE] as well as CEP192 significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	cep192	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of pericentrin or CDK5RAP2 as well as [GENE] significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	pericentrin	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of [GENE] CDK5RAP2 or CEP192 had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	cdk5rap2	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of pericentrin [GENE] or CEP192 had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	cep192	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of pericentrin CDK5RAP2 or [GENE] had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	sas6	depletion	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by [GENE] [EXPE] using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of PLK4 inhibition 
2021	PMC7812875	sas6	inhibition	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by [GENE] depletion using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of PLK4 [EXPE] 
2021	PMC7812875	plk4	depletion	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by SAS6 [EXPE] using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of [GENE] inhibition 
2021	PMC7812875	plk4	inhibition	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of [GENE] [EXPE] 
2021	PMC7812875	sas6	depletion	 (C)  PCM poles were observed in one-centrosome spindles induced by SAS6 depletion.	   C   PCM poles were observed in one-centrosome spindles induced by [GENE] [EXPE] 
2021	PMC7812875	pericentrin	time-lapse	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used [EXPE] fluorescence microscopy to track the dynamics of endogenous [GENE] or CDK5RAP2 tagged with mCherry as markers of PCM 
2021	PMC7812875	pericentrin	microscopy	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used time-lapse fluorescence [EXPE] to track the dynamics of endogenous [GENE] or CDK5RAP2 tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	time-lapse	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used [EXPE] fluorescence microscopy to track the dynamics of endogenous pericentrin or [GENE] tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	microscopy	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used time-lapse fluorescence [EXPE] to track the dynamics of endogenous pericentrin or [GENE] tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	depletion	On the other hand, depletion of the PCM scaffold proteins CDK5RAP2 and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells ( Fig. 2, C–E ;  Fig. S1, G–I ;  Videos 15 ,  17 ,  18 ,  23 ,  25 , and  26 ).	 On the other hand [EXPE] of the PCM scaffold proteins [GENE] and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells   Fig 2 C–E ;  Fig S1 G–I ;  Videos 15   17   18   23   25  and  26   
2021	PMC7812875	pericentrin	depletion	On the other hand, depletion of the PCM scaffold proteins CDK5RAP2 and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells ( Fig. 2, C–E ;  Fig. S1, G–I ;  Videos 15 ,  17 ,  18 ,  23 ,  25 , and  26 ).	 On the other hand [EXPE] of the PCM scaffold proteins CDK5RAP2 and [GENE] are known to have little effect on spindle formation in two- or zero-centrosome cells   Fig 2 C–E ;  Fig S1 G–I ;  Videos 15   17   18   23   25  and  26   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of CDK5RAP2 or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however, this effect was not observed in two-centrosome cells ( Fig. 4, A and B ).	 We found that [EXPE] of [GENE] or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however this effect was not observed in two-centrosome cells   Fig 4 A and B   
2021	PMC7812875	pericentrin	depletion	We found that depletion of CDK5RAP2 or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however, this effect was not observed in two-centrosome cells ( Fig. 4, A and B ).	 We found that [EXPE] of CDK5RAP2 or [GENE] caused arrest of one-centrosome cells in mitosis with monopolar spindles; however this effect was not observed in two-centrosome cells   Fig 4 A and B   
2021	PMC7812875	cdk5rap2	depletion	Upon depletion of CDK5RAP2 or pericentrin, the separation of two NuMA foci was normally detectable in early mitosis ( Fig. 4, C and D ;  Videos 8 ,  9 , and  10 ), while the time from nuclear envelope breakdown (NEBD) to cytokinesis was prolonged ( Fig. 4, C, E, and F ;  Videos 8 ,  9 , and  10 ).	 Upon [EXPE] of [GENE] or pericentrin the separation of two NuMA foci was normally detectable in early mitosis   Fig 4 C and D ;  Videos 8   9  and  10   while the time from nuclear envelope breakdown  NEBD  to cytokinesis was prolonged   Fig 4 C E and F ;  Videos 8   9  and  10   
2021	PMC7812875	pericentrin	depletion	Upon depletion of CDK5RAP2 or pericentrin, the separation of two NuMA foci was normally detectable in early mitosis ( Fig. 4, C and D ;  Videos 8 ,  9 , and  10 ), while the time from nuclear envelope breakdown (NEBD) to cytokinesis was prolonged ( Fig. 4, C, E, and F ;  Videos 8 ,  9 , and  10 ).	 Upon [EXPE] of CDK5RAP2 or [GENE] the separation of two NuMA foci was normally detectable in early mitosis   Fig 4 C and D ;  Videos 8   9  and  10   while the time from nuclear envelope breakdown  NEBD  to cytokinesis was prolonged   Fig 4 C E and F ;  Videos 8   9  and  10   
2021	PMC7812875	pericentrin	inhibitor	Next, by using proTAME (APC/C inhibitor) treatment, we arrested pericentrin or CDK5RAP2-depleted HeLa cells with one centrosome in metaphase to artificially induce bipolar spindle formation.	 Next by using proTAME  APC/C [EXPE]  treatment we arrested [GENE] or CDK5RAP2-depleted HeLa cells with one centrosome in metaphase to artificially induce bipolar spindle formation 
2021	PMC7812875	cep192	immunofluorescence	Immunofluorescence analysis revealed that in these HeLa cells, the degree of CEP192 localization at the acentrosomal spindle poles was significantly reduced compared with that in control cells ( Fig. 4, G–I ).	 [EXPE] analysis revealed that in these HeLa cells the degree of [GENE] localization at the acentrosomal spindle poles was significantly reduced compared with that in control cells   Fig 4 G–I   
2021	PMC7812875	gt335	sirna	  (A)  Mitotic spindle structures upon siRNA treatment with or without 500 nM centrinone B. Green, red, and blue represent GT335, α-tubulin, and DNA, respectively.	    A   Mitotic spindle structures upon [EXPE] treatment with or without 500 nM centrinone B Green red and blue represent [GENE] α-tubulin and DNA respectively 
2021	PMC7812875	cep192	assay	 (I)  The signal intensity of CEP192 on acentrosomal spindle poles in G. Line and error bars represent the mean and SD ( n  = 3, triplicates,  n  ≥ 20 cells for each assay).	   I   The signal intensity of [GENE] on acentrosomal spindle poles in G Line and error bars represent the mean and SD   n  = 3 triplicates  n  ≥ 20 cells for each [EXPE]  
2021	PMC7812875	pericentrin	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether [GENE] and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and [GENE] are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or CDK5RAP2 
2021	PMC7812875	pericentrin	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of [GENE] or CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or [GENE] 
2021	PMC7812875	pericentrin	immunostaining	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through [EXPE] we found that in cells with one centrosome depletion of [GENE] or CDK5RAP2 induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	pericentrin	depletion	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through immunostaining we found that in cells with one centrosome [EXPE] of [GENE] or CDK5RAP2 induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	immunostaining	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through [EXPE] we found that in cells with one centrosome depletion of pericentrin or [GENE] induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through immunostaining we found that in cells with one centrosome [EXPE] of pericentrin or [GENE] induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	Since siRNA-mediated depletion reduces the total expression level of CDK5RAP2 and pericentrin, it is difficult to analyze the function of the PCM components specifically at PCM poles ( Fig. 4 ).	 Since siRNA-mediated [EXPE] reduces the total expression level of [GENE] and pericentrin it is difficult to analyze the function of the PCM components specifically at PCM poles   Fig 4   
2021	PMC7812875	pericentrin	depletion	Since siRNA-mediated depletion reduces the total expression level of CDK5RAP2 and pericentrin, it is difficult to analyze the function of the PCM components specifically at PCM poles ( Fig. 4 ).	 Since siRNA-mediated [EXPE] reduces the total expression level of CDK5RAP2 and [GENE] it is difficult to analyze the function of the PCM components specifically at PCM poles   Fig 4   
2021	PMC7812875	cep57	depletion	CEP57 provides a critical interface between the centriole and PCM, and depletion of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells ( Watanabe et al., 2019 ).	 [GENE] provides a critical interface between the centriole and PCM and [EXPE] of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells   Watanabe et al 2019   
2021	PMC7812875	cep57	depletion	CEP57 provides a critical interface between the centriole and PCM, and depletion of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells ( Watanabe et al., 2019 ).	 CEP57 provides a critical interface between the centriole and PCM and [EXPE] of [GENE] induces the fragmentation of PCM proteins in early mitosis of human cells   Watanabe et al 2019   
2021	PMC7812875	cep57	depletion	Given that 38.5% of one-centrosome cells assembled PCM poles by splitting PCM from the centrosome ( Fig. 3, A and D ;  Video 4 ), we hypothesized that upon CEP57 depletion, the PCM that is dissociated from the centrosome could be incorporated into the acentriolar pole in one-centrosome cells.	 Given that 385% of one-centrosome cells assembled PCM poles by splitting PCM from the centrosome   Fig 3 A and D ;  Video 4   we hypothesized that upon [GENE] [EXPE] the PCM that is dissociated from the centrosome could be incorporated into the acentriolar pole in one-centrosome cells 
2021	PMC7812875	pericentrin	depletion	As expected, the amount of pericentrin at PCM poles was significantly increased, presumably due to the increased PCM fragmentation at centriolar poles after CEP57 depletion ( Fig. 5, A–C ).	 As expected the amount of [GENE] at PCM poles was significantly increased presumably due to the increased PCM fragmentation at centriolar poles after CEP57 [EXPE]   Fig 5 A–C   
2021	PMC7812875	cep57	depletion	As expected, the amount of pericentrin at PCM poles was significantly increased, presumably due to the increased PCM fragmentation at centriolar poles after CEP57 depletion ( Fig. 5, A–C ).	 As expected the amount of pericentrin at PCM poles was significantly increased presumably due to the increased PCM fragmentation at centriolar poles after [GENE] [EXPE]   Fig 5 A–C   
2021	PMC7812875	cep57	depletion	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] [EXPE] on the mitotic processes of one-centrosome cells we performed time-lapse imaging of NuMA and microtubules 
2021	PMC7812875	cep57	time-lapse	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] depletion on the mitotic processes of one-centrosome cells we performed [EXPE] imaging of NuMA and microtubules 
2021	PMC7812875	cep57	imaging	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] depletion on the mitotic processes of one-centrosome cells we performed time-lapse [EXPE] of NuMA and microtubules 
2021	PMC7812875	cep57	depletion	We found that depletion of CEP57 promoted bipolar spindle formation more efficiently than in control cells and thereby shortened the mitotic duration ( Fig. 5, D–F ;  Videos 11  and  12 ).	 We found that [EXPE] of [GENE] promoted bipolar spindle formation more efficiently than in control cells and thereby shortened the mitotic duration   Fig 5 D–F ;  Videos 11  and  12   
2021	PMC7812875	cep57	depletion	CEP57 depletion leads to an increase of PCM at the acentriolar pole and facilitates spindle bipolarization in one-centrosome cells.	 [GENE] [EXPE] leads to an increase of PCM at the acentriolar pole and facilitates spindle bipolarization in one-centrosome cells 
2021	PMC7812875	cep57	depletion	  (A)  Mitotic spindle pole structures of one-centrosome cells upon CEP57 depletion.	    A   Mitotic spindle pole structures of one-centrosome cells upon [GENE] [EXPE] 
2021	PMC7812875	cep57	time-lapse	 (D)  Time-lapse observation of NuMA structures and microtubules upon CEP57 depletion.	   D   [EXPE] observation of NuMA structures and microtubules upon [GENE] depletion 
2021	PMC7812875	cep57	depletion	 (D)  Time-lapse observation of NuMA structures and microtubules upon CEP57 depletion.	   D   Time-lapse observation of NuMA structures and microtubules upon [GENE] [EXPE] 
2021	PMC7812875	cep57	depletion	*, P < 0.0001.  (G)  Frequency of mitotic spindle structures upon CEP57 depletion.	 * P < 00001   G   Frequency of mitotic spindle structures upon [GENE] [EXPE] 
2021	PMC7812875	plk1	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if [GENE] was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the PLK1 [EXPE] BI 2536  1 nM  and observed the amount of pericentrin at the centriolar pole and the spindle structure 
2021	PMC7812875	plk1	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the [GENE] [EXPE] BI 2536  1 nM  and observed the amount of pericentrin at the centriolar pole and the spindle structure 
2021	PMC7812875	pericentrin	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the PLK1 [EXPE] BI 2536  1 nM  and observed the amount of [GENE] at the centriolar pole and the spindle structure 
2021	PMC7812875	plk1	inhibitor	Treatment of two-centrosome cells with a low dose of the PLK1 inhibitor caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation ( Fig. 6, E–G ).	 Treatment of two-centrosome cells with a low dose of the [GENE] [EXPE] caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation   Fig 6 E–G   
2021	PMC7812875	pericentrin	inhibitor	Treatment of two-centrosome cells with a low dose of the PLK1 inhibitor caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation ( Fig. 6, E–G ).	 Treatment of two-centrosome cells with a low dose of the PLK1 [EXPE] caused chromosome congression errors and a slight reduction of [GENE] at centrosomes but did not affect bipolar spindle formation   Fig 6 E–G   
2021	PMC7812875	plk1	inhibition	In contrast, in one-centrosome cells, PLK1 inhibition prevented PCM pole formation and led to the formation of monopolar spindles ( Fig. 6, E and F ).	 In contrast in one-centrosome cells [GENE] [EXPE] prevented PCM pole formation and led to the formation of monopolar spindles   Fig 6 E and F   
2021	PMC7812875	plk1	inhibition	In addition, PLK1 inhibition greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells ( Fig. 6 G ).	 In addition [GENE] [EXPE] greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells   Fig 6 G   
2021	PMC7812875	pericentrin	inhibition	In addition, PLK1 inhibition greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells ( Fig. 6 G ).	 In addition PLK1 [EXPE] greatly reduced the level of [GENE] at the centriolar pole compared with the level recorded in two-centrosome cells   Fig 6 G   
2021	PMC7812875	plk1	assay	 (D)  Frequency of localization of phosphorylated PLK1 in C ( n  = 6, triplicates, two independent experiments, at least 20 cells in each assay).	   D   Frequency of localization of phosphorylated [GENE] in C   n  = 6 triplicates two independent experiments at least 20 cells in each [EXPE]  
2021	PMC7812875	plk1	inhibition	 (E)  Mitotic spindle structures upon PLK1 inhibition (1 nM of BI 2536) with or without 100 nM of centrinone.	   E   Mitotic spindle structures upon [GENE] [EXPE]  1 nM of BI 2536  with or without 100 nM of centrinone 
2021	PMC7812875	pericentrin	depletion	We subsequently analyzed the spindle length upon depletion of pericentrin or CDK5RAP2 in HeLa cells.	 We subsequently analyzed the spindle length upon [EXPE] of [GENE] or CDK5RAP2 in HeLa cells 
2021	PMC7812875	cdk5rap2	depletion	We subsequently analyzed the spindle length upon depletion of pericentrin or CDK5RAP2 in HeLa cells.	 We subsequently analyzed the spindle length upon [EXPE] of pericentrin or [GENE] in HeLa cells 
2021	PMC7812875	pericentrin	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that [EXPE] of [GENE] significantly reduced the spindle length compared with that of control cells whereas depletion of CDK5RAP2 had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	pericentrin	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that depletion of [GENE] significantly reduced the spindle length compared with that of control cells whereas [EXPE] of CDK5RAP2 had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that [EXPE] of pericentrin significantly reduced the spindle length compared with that of control cells whereas depletion of [GENE] had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells whereas [EXPE] of [GENE] had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	pericentrin	depletion	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon [EXPE] of [GENE] we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	live-cell	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon depletion of [GENE] we performed [EXPE] imaging of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	imaging	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon depletion of [GENE] we performed live-cell [EXPE] of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	depletion	Depletion of pericentrin delayed the elongation of two spindle poles ( Fig. 7, E and F ;  Fig. S4, A and B ;  Videos 13 ,  14 ,  27 , and  28 ).	 [EXPE] of [GENE] delayed the elongation of two spindle poles   Fig 7 E and F ;  Fig S4 A and B ;  Videos 13   14   27  and  28   
2021	PMC7812875	pericentrin	time-lapse	 (E)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin in two-centrosome HeLa cells were observed with a 40× objective.	   E   [EXPE] observation of the structure of microtubules upon depletion of [GENE] in two-centrosome HeLa cells were observed with a 40× objective 
2021	PMC7812875	pericentrin	depletion	 (E)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin in two-centrosome HeLa cells were observed with a 40× objective.	   E   Time-lapse observation of the structure of microtubules upon [EXPE] of [GENE] in two-centrosome HeLa cells were observed with a 40× objective 
2021	PMC7812875	pericentrin	depletion	The spindle length of A549 (H) and U2OS (I) cells upon depletion of pericentrin ( n  > 40 from two independent experiments).	 The spindle length of A549  H  and U2OS  I  cells upon [EXPE] of [GENE]   n  > 40 from two independent experiments  
2021	PMC7812875	pericentrin	time-lapse	  (A)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin.	    A   [EXPE] observation of the structure of microtubules upon depletion of [GENE] 
2021	PMC7812875	pericentrin	depletion	  (A)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin.	    A   Time-lapse observation of the structure of microtubules upon [EXPE] of [GENE] 
2021	PMC7812875	pericentrin	depletion	Furthermore, we tested the effect of depletion of pericentrin on the spindle elongation of various cell types.	 Furthermore we tested the effect of [EXPE] of [GENE] on the spindle elongation of various cell types 
2021	PMC7812875	pericentrin	depletion	On the other hand, in some cell types (RPE1, GI1, and SKOV3), the spindle length upon depletion of pericentrin was not altered compared with that observed in control cells ( Fig. S4, C–F ).	 On the other hand in some cell types  RPE1 GI1 and SKOV3  the spindle length upon [EXPE] of [GENE] was not altered compared with that observed in control cells   Fig S4 C–F   
2021	PMC7938805	foxj1	immunostaining	(C) Immunostaining of FoxJ1 in differentiated E1 cells cultured in ALI for 21 days.	  C  [EXPE] of [GENE] in differentiated E1 cells cultured in ALI for 21 days 
2021	PMC7938805	deup1	doxycycline-inducible	Through lenti-virus-mediated gene transfer, we generated E1 cells that expressed Deup1 and Centrin2 tagged with mScarlet I and GFP, respectively, with a doxycycline-inducible expression promoter ( Fig.S1F,G ).	 Through lenti-virus-mediated gene transfer we generated E1 cells that expressed [GENE] and Centrin2 tagged with mScarlet I and GFP respectively with a [EXPE] expression promoter   FigS1FG   
2021	PMC7938805	fig1	live cell	Using live cell imaging, we clearly observed mScarlet I-Deup1 foci associated with Centrin2-GFP foci in differentiating E1 cells (ALI for 5 days) ( Fig.1 E).	 Using [EXPE] imaging we clearly observed mScarlet I-Deup1 foci associated with Centrin2-GFP foci in differentiating E1 cells  ALI for 5 days    [GENE] E  
2021	PMC7938805	fig1	imaging	Using live cell imaging, we clearly observed mScarlet I-Deup1 foci associated with Centrin2-GFP foci in differentiating E1 cells (ALI for 5 days) ( Fig.1 E).	 Using live cell [EXPE] we clearly observed mScarlet I-Deup1 foci associated with Centrin2-GFP foci in differentiating E1 cells  ALI for 5 days    [GENE] E  
2021	PMC7938805	deup1	frap	We performed FRAP analysis of mScarlet I-Deup1 in undifferentiated E1 cells to further characterize the properties of Deup1 assemblies.	 We performed [EXPE] analysis of mScarlet I-Deup1 in undifferentiated E1 cells to further characterize the properties of [GENE] assemblies 
2021	PMC7938805	deup1	photobleaching	We found that, even in the undifferentiated cells, mScarlet I-Deup1 showed a slow turnover within the Deup1 assemblies (recovery: 6±3% at 290 s after photobleaching) ( Fig.2 B).	 We found that even in the undifferentiated cells mScarlet I-Deup1 showed a slow turnover within the [GENE] assemblies  recovery: 6±3% at 290 s after [EXPE]    Fig2 B  
2021	PMC7938805	deup1	frap	We performed FRAP analysis of mScarlet I-Deup1 to investigate the biophysical properties of the Deup1 assemblies formed  in vitro .	 We performed [EXPE] analysis of mScarlet I-Deup1 to investigate the biophysical properties of the [GENE] assemblies formed  in vitro  
2021	PMC7938805	deup1	photobleaching	Consistent with the results observed in cells, we found that turnover of mScarlet I-Deup1 was barely observed within the Deup1 assemblies  in vitro  (recovery: 1±1% t 290 s after photobleaching) ( Fig.4 A).	 Consistent with the results observed in cells we found that turnover of mScarlet I-Deup1 was barely observed within the [GENE] assemblies  in vitro   recovery: 1±1% t 290 s after [EXPE]    Fig4 A  
2021	PMC7938805	fig4	photobleaching	Consistent with the results observed in cells, we found that turnover of mScarlet I-Deup1 was barely observed within the Deup1 assemblies  in vitro  (recovery: 1±1% t 290 s after photobleaching) ( Fig.4 A).	 Consistent with the results observed in cells we found that turnover of mScarlet I-Deup1 was barely observed within the Deup1 assemblies  in vitro   recovery: 1±1% t 290 s after [EXPE]    [GENE] A  
2021	PMC7938805	deup1	bleaching	In addition, internal rearrangement in Deup1 assemblies was undetectable following partial bleaching of the fluorescence of mScarlet I-Deup1 assemblies ( Fig.S4B ).	 In addition internal rearrangement in [GENE] assemblies was undetectable following partial [EXPE] of the fluorescence of mScarlet I-Deup1 assemblies   FigS4B   
2021	PMC7938805	deup1	purified	The purified N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro  (as observed with full-length Deup1), whereas the C-terminus fragments did not ( Fig.5 C;  FigsS4C and S5E ).	 The [EXPE] N-terminus fragment of [GENE] also showed strong self-assembly properties  in vitro   as observed with full-length Deup1  whereas the C-terminus fragments did not   Fig5 C;  FigsS4C and S5E   
2021	PMC7938805	deup1	purified	The purified N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro  (as observed with full-length Deup1), whereas the C-terminus fragments did not ( Fig.5 C;  FigsS4C and S5E ).	 The [EXPE] N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro   as observed with full-length [GENE]  whereas the C-terminus fragments did not   Fig5 C;  FigsS4C and S5E   
2019	PMC6777370	fig1	photobleaching	Although fluorescence signals gradually decreased over time courses, presumably due to photobleaching ( Fig.1 A), the decrease was subtle and at least one complete oscillation cycle was successfully tracked in each observation.	 Although fluorescence signals gradually decreased over time courses presumably due to [EXPE]   [GENE] A  the decrease was subtle and at least one complete oscillation cycle was successfully tracked in each observation 
2019	PMC6777370	plk4	inhibitor	To further verify the behavior of Plk4-mClover at centrioles, we monitored the effect of treatment with a Plk4 inhibitor, centrinone ( Wong et al., 2015 ).	 To further verify the behavior of Plk4-mClover at centrioles we monitored the effect of treatment with a [GENE] [EXPE] centrinone   Wong et al 2015   
2019	PMC6777370	fig1	immunofluorescence	This observation aside, the majority of the centriolar HsSAS6 we observed started accumulating at the centrioles later in the cell cycle, regardless of the tags we used ( Fig.1 D;  Fig.S2B ), as previously observed via immunofluorescence ( Keller et al., 2014 ;  Strnad et al., 2007 ).	 This observation aside the majority of the centriolar HsSAS6 we observed started accumulating at the centrioles later in the cell cycle regardless of the tags we used   [GENE] D;  FigS2B   as previously observed via [EXPE]   Keller et al 2014 ;  Strnad et al 2007   
2019	PMC6777370	plk4	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged [GENE] and STIL  A  or HsSAS6  B  
2019	PMC6777370	stil	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged Plk4 and [GENE]  A  or HsSAS6  B  
2019	PMC6777370	stil	immunofluorescence	This is consistent with previous immunofluorescence observations, as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ).	 This is consistent with previous [EXPE] observations as well as the model in which centriolar loading of [GENE] promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern   Arquint et al 2015 ;  Ohta et al 2018   2014   
2019	PMC6777370	plk4	immunofluorescence	This is consistent with previous immunofluorescence observations, as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ).	 This is consistent with previous [EXPE] observations as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of [GENE] to form the single-focus pattern   Arquint et al 2015 ;  Ohta et al 2018   2014   
2019	PMC6777370	stil	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since [GENE] and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	plk4	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar [GENE]   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	plk4	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar [GENE] in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	stil	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of [GENE] or HsSAS6  as well as in a control culture  
2019	PMC6777370	stil	depletion	In stark contrast, upon depletion of STIL or HsSAS6, centriolar Plk4-mClover remained constant after reaching its fluorescence peak throughout the rest of the period until the next mitosis ( Fig.3 A).	 In stark contrast upon [EXPE] of [GENE] or HsSAS6 centriolar Plk4-mClover remained constant after reaching its fluorescence peak throughout the rest of the period until the next mitosis   Fig3 A  
2019	PMC6777370	plk4	immunofluorescence	Indeed, when observed by immunofluorescence microscopy at a higher resolution, in line with previous observations ( Ohta et al., 2014 ), centriolar Plk4 primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells ( Fig.3 B).	 Indeed when observed by [EXPE] microscopy at a higher resolution in line with previous observations   Ohta et al 2014   centriolar [GENE] primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells   Fig3 B  
2019	PMC6777370	plk4	microscopy	Indeed, when observed by immunofluorescence microscopy at a higher resolution, in line with previous observations ( Ohta et al., 2014 ), centriolar Plk4 primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells ( Fig.3 B).	 Indeed when observed by immunofluorescence [EXPE] at a higher resolution in line with previous observations   Ohta et al 2014   centriolar [GENE] primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells   Fig3 B  
2019	PMC6777370	stil	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of [GENE] or HsSAS6 on the behavior of centriolar Plk4 
2019	PMC6777370	plk4	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of STIL or HsSAS6 on the behavior of centriolar [GENE] 
2019	PMC6777370	stil	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of [GENE] or HsSAS6 on the spatial patterning of centriolar Plk4 
2019	PMC6777370	plk4	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of STIL or HsSAS6 on the spatial patterning of centriolar [GENE] 
2019	PMC6777370	plk4	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	plk4	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	stil	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	stil	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	pericentrin	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pericentrin	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pcnt	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	pcnt	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	plk4	immunofluorescence	To quantify the spatial pattern of Plk4, we calculated ring-filling indices for centriolar Plk4 from the immunofluorescence images.	 To quantify the spatial pattern of [GENE] we calculated ring-filling indices for centriolar Plk4 from the [EXPE] images 
2019	PMC6777370	plk4	immunofluorescence	To quantify the spatial pattern of Plk4, we calculated ring-filling indices for centriolar Plk4 from the immunofluorescence images.	 To quantify the spatial pattern of Plk4 we calculated ring-filling indices for centriolar [GENE] from the [EXPE] images 
2019	PMC6777370	stil	immunofluorescence	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig.3 D).	 We confirmed by using [EXPE] microscopy that [GENE] is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa   Fig3 D  
2019	PMC6777370	stil	microscopy	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig.3 D).	 We confirmed by using immunofluorescence [EXPE] that [GENE] is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa   Fig3 D  
2019	PMC6777370	stil	depleted	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig.3 D).	 We confirmed by using immunofluorescence microscopy that [GENE] is mostly absent from centrioles in cells that are [EXPE] of HsSAS6 and vice versa   Fig3 D  
2019	PMC6777370	stil	depletion	(D) Simulated effect of STIL or HsSAS6 depletion.	  D  Simulated effect of [GENE] or HsSAS6 [EXPE] 
2019	PMC6777370	fig4	live-cell	Our live-cell imaging did not distinguish between such subclasses, so it is the data shown in  Fig.4 B that should be compared with the live-cell imaging data.	 Our [EXPE] imaging did not distinguish between such subclasses so it is the data shown in  [GENE] B that should be compared with the live-cell imaging data 
2019	PMC6777370	fig4	imaging	Our live-cell imaging did not distinguish between such subclasses, so it is the data shown in  Fig.4 B that should be compared with the live-cell imaging data.	 Our live-cell [EXPE] did not distinguish between such subclasses so it is the data shown in  [GENE] B that should be compared with the live-cell imaging data 
2019	PMC6777370	fig4	live-cell	Our live-cell imaging did not distinguish between such subclasses, so it is the data shown in  Fig.4 B that should be compared with the live-cell imaging data.	 Our live-cell imaging did not distinguish between such subclasses so it is the data shown in  [GENE] B that should be compared with the [EXPE] imaging data 
2019	PMC6777370	fig4	imaging	Our live-cell imaging did not distinguish between such subclasses, so it is the data shown in  Fig.4 B that should be compared with the live-cell imaging data.	 Our live-cell imaging did not distinguish between such subclasses so it is the data shown in  [GENE] B that should be compared with the live-cell [EXPE] data 
2019	PMC6777370	stil	depletion	Centriolar accumulation of HsSAS6 was significantly attenuated with the depletion of STIL and vice versa ( Fig.4 D).	 Centriolar accumulation of HsSAS6 was significantly attenuated with the [EXPE] of [GENE] and vice versa   Fig4 D  
2019	PMC6777370	fig4	depletion	Centriolar accumulation of HsSAS6 was significantly attenuated with the depletion of STIL and vice versa ( Fig.4 D).	 Centriolar accumulation of HsSAS6 was significantly attenuated with the [EXPE] of STIL and vice versa   [GENE] D  
2019	PMC6777370	fig4	live-cell	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  [GENE] E Our [EXPE] imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	fig4	imaging	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  [GENE] E Our live-cell [EXPE] of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	stil	live-cell	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig4 E Our [EXPE] imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both [GENE] and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	stil	imaging	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig4 E Our live-cell [EXPE] of single cells throughout the cell cycle demonstrated that the centriolar loading of both [GENE] and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	plk4	live-cell	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig4 E Our [EXPE] imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in [GENE] after it has reached its fluorescence peak 
2019	PMC6777370	plk4	imaging	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig.4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig4 E Our live-cell [EXPE] of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in [GENE] after it has reached its fluorescence peak 
2019	PMC6777370	sas6	assay	This is analogous to a previous model based on an  in vitro  reconstitution assay using  Chlamydomonas reinhardtii  SAS6 and mathematical modeling, which suggested that the cartwheel assembly mechanism was mediated by the  Chlamydomonas  protein Bld10p ( Klein et al., 2016 ;  Goldie et al., 2017 ;  Nievergelt et al., 2018 ).	 This is analogous to a previous model based on an  in vitro  reconstitution [EXPE] using  Chlamydomonas reinhardtii  [GENE] and mathematical modeling which suggested that the cartwheel assembly mechanism was mediated by the  Chlamydomonas  protein Bld10p   Klein et al 2016 ;  Goldie et al 2017 ;  Nievergelt et al 2018   
2019	PMC6777370	plk4	suppress	Concurrently, at the procentriole assembly site, this increased quantity of the protein complex may suppress the dissociation of active Plk4 from centrioles via direct interaction, while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles.	 Concurrently at the procentriole assembly site this increased quantity of the protein complex may [EXPE] the dissociation of active [GENE] from centrioles via direct interaction while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles 
2019	PMC6777370	plk4	suppress	Concurrently, at the procentriole assembly site, this increased quantity of the protein complex may suppress the dissociation of active Plk4 from centrioles via direct interaction, while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles.	 Concurrently at the procentriole assembly site this increased quantity of the protein complex may [EXPE] the dissociation of active Plk4 from centrioles via direct interaction while promoting the activation and subsequent dissociation of neighboring [GENE] molecules from centrioles 
2019	PMC6829667	plk4	confocal	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc [EXPE] microscopy after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	confocal microscopy	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc [EXPE] after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	microscopy	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc confocal [EXPE] after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	live imaging	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   [EXPE] of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal microscopy 
2019	PMC6829667	plk4	imaging	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live [EXPE] of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal microscopy 
2019	PMC6829667	plk4	confocal	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc [EXPE] microscopy 
2019	PMC6829667	plk4	confocal microscopy	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc [EXPE] 
2019	PMC6829667	plk4	microscopy	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal [EXPE] 
2019	PMC6829667	plk4	confocal	Scale bars, 10 µm.  (B)  Confocal immunofluorescence images of endogenous Plk4, with deconvolution.	 Scale bars 10 µm   B   [EXPE] immunofluorescence images of endogenous [GENE] with deconvolution 
2019	PMC6829667	plk4	immunofluorescence	Scale bars, 10 µm.  (B)  Confocal immunofluorescence images of endogenous Plk4, with deconvolution.	 Scale bars 10 µm   B   Confocal [EXPE] images of endogenous [GENE] with deconvolution 
2019	PMC6829667	plk4	stained	Synchronized cells were fixed at the indicated time after thymidine release and stained with antibodies against Plk4 and CEP152 (centriolar marker).	 Synchronized cells were fixed at the indicated time after thymidine release and [EXPE] with antibodies against [GENE] and CEP152  centriolar marker  
2019	PMC6829667	cep152	stained	Synchronized cells were fixed at the indicated time after thymidine release and stained with antibodies against Plk4 and CEP152 (centriolar marker).	 Synchronized cells were fixed at the indicated time after thymidine release and [EXPE] with antibodies against Plk4 and [GENE]  centriolar marker  
2019	PMC6829667	plk4	immunofluorescence	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via [EXPE] confocal microscopy the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	confocal	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence [EXPE] microscopy the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	confocal microscopy	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence [EXPE] the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	microscopy	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence confocal [EXPE] the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	sted	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used [EXPE] super-resolution microscopy to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	super-resolution	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used STED [EXPE] microscopy to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	microscopy	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used STED super-resolution [EXPE] to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	super-resolution	Discrete and periodic Plk4 ring patterns at the super-resolution scale.	 Discrete and periodic [GENE] ring patterns at the [EXPE] scale 
2019	PMC6829667	plk4	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar [GENE]  from different samples  with or without deconvolution  A  and the oval profile of Plk4  B  
2019	PMC6829667	plk4	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar [GENE]  from different samples  with or without deconvolution  A  and the oval profile of Plk4  B  
2019	PMC6829667	oval	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar Plk4  from different samples  with or without deconvolution  A  and the [GENE] profile of Plk4  B  
2019	PMC6829667	oval	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar Plk4  from different samples  with or without deconvolution  A  and the [GENE] profile of Plk4  B  
2019	PMC6829667	plk4	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar Plk4  from different samples  with or without deconvolution  A  and the oval profile of [GENE]  B  
2019	PMC6829667	plk4	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar Plk4  from different samples  with or without deconvolution  A  and the oval profile of [GENE]  B  
2019	PMC6829667	plk4	sted	 (C)  An array plot of all STED profiles of Plk4 ( n  = 37 cells).	   C   An array plot of all [EXPE] profiles of [GENE]   n  = 37 cells  
2019	PMC6829667	cep152	sted	The angle shown in the inset STED image (*) corresponds to the distance indicated in yellow (*) in the profile in B.  (E)  Representative STED images and quantification of CEP152 spatial patterns.	 The angle shown in the inset [EXPE] image  *  corresponds to the distance indicated in yellow  *  in the profile in B   E   Representative STED images and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep152	sted	The angle shown in the inset STED image (*) corresponds to the distance indicated in yellow (*) in the profile in B.  (E)  Representative STED images and quantification of CEP152 spatial patterns.	 The angle shown in the inset STED image  *  corresponds to the distance indicated in yellow  *  in the profile in B   E   Representative [EXPE] images and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep192	sted	 (F)  Representative STED image and quantification of CEP192 spatial patterns.	   F   Representative [EXPE] image and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep152	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to [GENE] the main scaffold of centriolar Plk4 to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4 
2019	PMC6829667	plk4	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to CEP152 the main scaffold of centriolar [GENE] to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4 
2019	PMC6829667	plk4	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to CEP152 the main scaffold of centriolar Plk4 to identify the factor generating the sixfold symmetry of the discrete ring patterns of [GENE] 
2019	PMC6829667	cep152	sted	Via STED observations using an antibody to the N-terminal region of CEP152, we found that CEP152 also showed periodic patterns ( Fig. 2 E ).	 Via [EXPE] observations using an antibody to the N-terminal region of [GENE] we found that CEP152 also showed periodic patterns   Fig 2 E   
2019	PMC6829667	cep152	sted	Via STED observations using an antibody to the N-terminal region of CEP152, we found that CEP152 also showed periodic patterns ( Fig. 2 E ).	 Via [EXPE] observations using an antibody to the N-terminal region of CEP152 we found that [GENE] also showed periodic patterns   Fig 2 E   
2019	PMC6829667	cep192	sted	We therefore similarly quantified the spatial pattern of centriolar CEP192 by STED analysis.	 We therefore similarly quantified the spatial pattern of centriolar [GENE] by [EXPE] analysis 
2019	PMC6829667	plk4	sted	This variation in the spatial and temporal patterns simulated may explain the variety of the spatial patterns of Plk4 observed in our STED analysis.	 This variation in the spatial and temporal patterns simulated may explain the variety of the spatial patterns of [GENE] observed in our [EXPE] analysis 
2019	PMC6829667	plk4	overexpression	 (B)  Representative simulation results using overexpression of Plk4 or STIL.	   B   Representative simulation results using [EXPE] of [GENE] or STIL 
2019	PMC6829667	stil	overexpression	 (B)  Representative simulation results using overexpression of Plk4 or STIL.	   B   Representative simulation results using [EXPE] of Plk4 or [GENE] 
2019	PMC6829667	plk4	overexpression	Overexpression of Plk4, STIL, or HsSAS6 is known to induce overduplication of centrioles ( Habedanck et al., 2005 ;  Kleylein-Sohn et al., 2007 ;  Strnad et al., 2007 ;  Tang et al., 2011 ;  Arquint et al., 2012 ;  Vulprecht et al., 2012 ).	 [EXPE] of [GENE] STIL or HsSAS6 is known to induce overduplication of centrioles   Habedanck et al 2005 ;  Kleylein-Sohn et al 2007 ;  Strnad et al 2007 ;  Tang et al 2011 ;  Arquint et al 2012 ;  Vulprecht et al 2012   
2019	PMC6829667	stil	overexpression	Overexpression of Plk4, STIL, or HsSAS6 is known to induce overduplication of centrioles ( Habedanck et al., 2005 ;  Kleylein-Sohn et al., 2007 ;  Strnad et al., 2007 ;  Tang et al., 2011 ;  Arquint et al., 2012 ;  Vulprecht et al., 2012 ).	 [EXPE] of Plk4 [GENE] or HsSAS6 is known to induce overduplication of centrioles   Habedanck et al 2005 ;  Kleylein-Sohn et al 2007 ;  Strnad et al 2007 ;  Tang et al 2011 ;  Arquint et al 2012 ;  Vulprecht et al 2012   
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of [GENE]  the cytosolic level of Plk4 was set five times higher  multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of Plk4  the cytosolic level of [GENE] was set five times higher  multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of Plk4  the cytosolic level of Plk4 was set five times higher  multiple [GENE] foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of [GENE] the simulated Plk4 patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of STIL 
2019	PMC6829667	plk4	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of Plk4 the simulated [GENE] patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of STIL 
2019	PMC6829667	stil	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of Plk4 the simulated Plk4 patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of [GENE] 
2019	PMC6829667	stil	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of [GENE] was then simulated by setting a lower threshold  one fifth  of STIL binding to Plk4 foci 
2019	PMC6829667	stil	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of STIL was then simulated by setting a lower threshold  one fifth  of [GENE] binding to Plk4 foci 
2019	PMC6829667	plk4	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of STIL was then simulated by setting a lower threshold  one fifth  of STIL binding to [GENE] foci 
2019	PMC6829667	plk4	overexpression	Interestingly, the numbers of stabilized Plk4 foci in the overexpression simulations did not exceed six, potentially explaining the limitation in the maximum number of overduplicated daughter centrioles.	 Interestingly the numbers of stabilized [GENE] foci in the [EXPE] simulations did not exceed six potentially explaining the limitation in the maximum number of overduplicated daughter centrioles 
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that [GENE] is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that Plk4 is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of [GENE] and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] [EXPE] centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] inhibitor centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 [EXPE] centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 inhibitor centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	cep152	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	plk4	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that [GENE] is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that Plk4 is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of [GENE] and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] [EXPE] centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] inhibitor centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 [EXPE] centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 inhibitor centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	cep152	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	plk4	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of [GENE] and its scaffold 
